To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RPL11andTCEB3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
876 representative clones for gene RPL11andTCEB3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA333869 hippocampus .a 1 to 567 2 to 568   tiling clone, capped   567/567
(100 %)
1 diff
(99.9 %id)
DB461774 testis .a 173 to 658 1 to 486       486/486
(100 %)
0 diff
(100 %id)
NM_003198.2   .a 211 to 5152 1 to 4942 exact RefSeq, AAA   4942/4942
(100 %)
0 diff
(100 %id)
AK310229 testis .a 225 to 2685 1 to 2461 exact     2461/2461
(100 %)
0 diff
(100 %id)
BP309371 brain .a 271 to 859 1 to 589       589/589
(100 %)
0 diff
(100 %id)
DA475342   .a 272 to 832 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DB081667 testis .a 272 to 832 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DB277325 uterus .a 274 to 817 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
BG700805 brain, hippocampus .a 298 to 1060 1 to 763       763/763
(100 %)
16 diff
(98.0 %id)
BP359139 mammary gland .a 299 to 881 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
DB225322 trachea .a 300 to 867 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA655790   .a 301 to 857 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
AU130075   .a 301 to 1138 2 to 839   capped   838/843
(99 %)
5 diff
(99.5 %id)
BI462097 testis .a 311 to 1047 1 to 740       740/743
(99 %)
8 diff
(99.0 %id)
BM832727 stomach .a 316 to 870 1 to 555       555/555
(100 %)
2 diff
(99.7 %id)
DB265477 uterus .a 316 to 880 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DA021477   .a 317 to 881 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA027628   .a 317 to 883 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DA105679 cerebellum .a 317 to 904 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DA228308 brain .a 317 to 870 2 to 555   capped   554/556
(99 %)
3 diff
(99.5 %id)
DA407468 thalamus .a 317 to 880 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
AL527702 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 317 to 1294 1 to 974       974/1038
(93 %)
20 diff
(98.1 %id)
DA479249   .a 317 to 881 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DA482694   .a 317 to 888 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA602064   .a 317 to 885 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
L47345 umbilical vein .a 317 to 2991 1 to 2674       2674/2676
(99 %)
4 diff
(99.9 %id)
DA657031   .a 317 to 888 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA658562   .a 317 to 876 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA709048   .a 317 to 865 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DN995766 breast cancer, Mammary gland (cancer tissue) .a 320 to 974 1 to 655       655/655
(100 %)
4 diff
(99.4 %id)
BU165440 eye, retinoblastoma .a 321 to 1146 18 to 845       828/859
(96 %)
18 diff
(98.0 %id)
AU132082   .a 321 to 1168 2 to 851   capped   850/850
(100 %)
15 diff
(98.3 %id)
AU130020   .a 323 to 1087 2 to 767   capped   766/766
(100 %)
7 diff
(99.1 %id)
BP249611 Kidney .a 325 to 906 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BQ269214 Pancreas, Purified pancreatic islet .a 325 to 960 13 to 648       636/648
(98 %)
5 diff
(99.3 %id)
DB100524 testis .a 326 to 928 2 to 604   capped   603/603
(100 %)
0 diff
(100 %id)
DB252985 uterus .a 326 to 893 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
BC002883 Lung, small cell carcinoma .a 327 to 2994 1 to 2668   available from MGC, AAA   2668/2668
(100 %)
1 diff
(100.0 %id)
BU164461 epithelioid carcinoma, Pancreas .a 329 to 1207 1 to 882       882/886
(99 %)
9 diff
(99.0 %id)
CD689600 normal nasopharynx .a 330 to 944 35 to 649       615/649
(94 %)
6 diff
(99.1 %id)
CA489271   .a 331 to 953 1 to 629       629/819
(76 %)
6 diff
(99.3 %id)
CN409629 embryonic stem cells, DMSO-treated H9 cellline .a 332 to 970 1 to 639       639/639
(100 %)
0 diff
(100 %id)
BU541810 carcinoma, cell line, Prostate .a 332 to 1230 1 to 906       906/910
(99 %)
11 diff
(98.8 %id)
DA311523 hippocampus .a 334 to 885 2 to 554   capped   553/553
(100 %)
2 diff
(99.7 %id)
BM906873 brain, hippocampus .a 337 to 1253 20 to 946       927/1109
(83 %)
36 diff
(96.8 %id)
AK313079 hippocampus .a 339 to 2667 1 to 2329       2329/2329
(100 %)
1 diff
(100.0 %id)
BG758551 B-cells, primary B-cells from tonsils (cell line) .a 339 to 1109 1 to 774       774/775
(99 %)
13 diff
(98.4 %id)
DA223103 brain .a 340 to 922 2 to 584   capped   583/583
(100 %)
1 diff
(99.9 %id)
DA871961 Prostate .a 340 to 885 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA871089 Prostate .a 343 to 897 2 to 558   capped   557/557
(100 %)
3 diff
(99.5 %id)
DA644388   .a 344 to 916 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
CR999804 T-Lymphocytes .a 344 to 1136 1 to 793       793/793
(100 %)
0 diff
(100 %id)
BM787886 stomach .a 345 to 958 1 to 614       614/614
(100 %)
0 diff
(100 %id)
DA481629   .a 346 to 909 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
BE797449 lung, small cell carcinoma .a 346 to 1238 1 to 887       887/989
(89 %)
25 diff
(97.5 %id)
CR990314 T-Lymphocytes .a 346 to 903 1 to 559       559/559
(100 %)
2 diff
(99.7 %id)
DA941979 Spleen .a 346 to 888 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
BM449824 melanotic melanoma, skin .a 347 to 1219 1 to 884       884/888
(99 %)
15 diff
(98.4 %id)
CV026459 mixed .a 349 to 931 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BE263868 lung, small cell carcinoma .a 353 to 948 1 to 598       598/598
(100 %)
2 diff
(99.7 %id)
CR595017 Neuroblastoma Cot 25-normalized .a 354 to 2957 1 to 2604   tiling clone,   2604/2604
(100 %)
0 diff
(100 %id)
AL528511 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 354 to 1402 1 to 1040       1040/1105
(94 %)
13 diff
(98.9 %id)
BQ212597 melanotic melanoma, skin .a 354 to 1207 1 to 864       864/867
(99 %)
14 diff
(98.4 %id)
BQ213229 large cell carcinoma, lung .a 357 to 1247 1 to 897       897/898
(99 %)
13 diff
(98.6 %id)
AF116729 heart .a 362 to 2999 1 to 2638   AAA   2638/2638
(100 %)
0 diff
(100 %id)
BE885298 leiomyosarcoma, uterus .a 362 to 1064 1 to 698       698/793
(88 %)
17 diff
(97.9 %id)
CR985340 T-Lymphocytes .a 362 to 1126 1 to 766       766/766
(100 %)
1 diff
(99.9 %id)
BE780606 eye, retinoblastoma .a 375 to 1205 1 to 829       829/877
(94 %)
20 diff
(97.8 %id)
AL042403 testis .a 416 to 1093 1 to 679       679/686
(98 %)
4 diff
(99.5 %id)
BJ993901 hepatoblastoma .a 460 to 939 1 to 480       480/480
(100 %)
0 diff
(100 %id)
BQ232598 large cell carcinoma, lung .a 480 to 1229 13 to 768       756/902
(83 %)
22 diff
(97.6 %id)
BQ417470 Pancreas, Purified pancreatic islet .a 486 to 1122 1 to 637       637/637
(100 %)
2 diff
(99.7 %id)
BG036847 adenocarcinoma, cell line, Prostate .a 488 to 1251 1 to 764       764/1107
(69 %)
21 diff
(98.2 %id)
BG115971 duodenal adenocarcinoma, cell line, small intestine .a 495 to 1224 1 to 740       740/1177
(62 %)
20 diff
(98.4 %id)
BX472097   .a 500 to 965 1 to 466       466/466
(100 %)
0 diff
(100 %id)
BE018499 cervix .a 548 to 1125 1 to 578       578/578
(100 %)
4 diff
(99.4 %id)
AI903518 breast .a 562 to 1011 1 to 450       450/450
(100 %)
0 diff
(100 %id)
BM824892 Ascites, stomach .a 583 to 1148 1 to 566       566/566
(100 %)
0 diff
(100 %id)
EL594317 epidermis, skin .a 656 to 1375 26 to 745       720/746
(96 %)
4 diff
(99.5 %id)
DA338495 hippocampus .a 738 to 1318 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
AA195443 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 749 to 1286 1 to 529   fully sequenced,   529/529
(100 %)
10 diff
(98.2 %id)
AA644530 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 783 to 987 1 to 205       205/205
(100 %)
14 diff
(93.2 %id)
BM825421 Ascites, stomach .a 809 to 1298 1 to 490       490/490
(100 %)
0 diff
(100 %id)
BU161550 melanotic melanoma, skin .a 814 to 1640 1 to 834       834/889
(93 %)
8 diff
(99.2 %id)
AI344128 colon, colon tumor, RER+ .a 817 to 1601 785 to 1       785/785
(100 %)
17 diff
(97.9 %id)
AA380718   .a 824 to 1087 1 to 264       264/264
(100 %)
0 diff
(100 %id)
TI_149305126   .a 829 to 1599 852 to 84   AAA   769/966
(79 %)
8 diff
(99.2 %id)
TI_154151487   .a 848 to 1512 80 to 745       666/666
(100 %)
20 diff
(97.0 %id)
TI_154152132   .a 848 to 1398 84 to 634       551/551
(100 %)
3 diff
(99.5 %id)
BP387796 pancreatic islet .a 876 to 1227 352 to 1       352/352
(100 %)
0 diff
(100 %id)
DB291689 uterus .a 877 to 1458 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
BG764286 melanotic melanoma, high MDR (cell line), skin .a 880 to 1684 1 to 814       814/814
(100 %)
14 diff
(98.3 %id)
AI344130 colon, colon tumor, RER+ .a 886 to 1601 717 to 1       717/723
(99 %)
15 diff
(98.0 %id)
TI_149292781   .a 906 to 1619 771 to 58       714/771
(92 %)
0 diff
(100 %id)
CD653124 Embryonic Stem cells .a 918 to 1674 35 to 788       754/868
(86 %)
9 diff
(99.0 %id)
CD655220 Embryonic Stem cells .a 927 to 1725 1 to 792       792/805
(98 %)
9 diff
(98.9 %id)
BM974753 lung .a 927 to 1599 691 to 19   AAA   673/673
(100 %)
0 diff
(100 %id)
CK004601 brain/CNS, Human Brain - Frontal Cortex .a 949 to 1596 1 to 647       647/649
(99 %)
4 diff
(99.4 %id)
AI862411 colon, colon tumor, RER+ .a 970 to 1601 632 to 1       632/636
(99 %)
7 diff
(98.9 %id)
BQ268940 Pancreas, Purified pancreatic islet .a 973 to 1598 626 to 1       626/626
(100 %)
0 diff
(100 %id)
BU685525 lung, Primary Lung Epithelial Cells .a 999 to 1599 619 to 19   AAA   601/601
(100 %)
1 diff
(99.9 %id)
CA848983 Pancreas, Purified pancreatic islet .a 1019 to 1281 1 to 263   fully sequenced,   263/263
(100 %)
0 diff
(100 %id)
CA848904 Pancreas, Purified pancreatic islet .a 1026 to 1602 577 to 1       577/577
(100 %)
0 diff
(100 %id)
CN409628 embryonic stem cells, cell lines H1, H7, andH9 .a 1054 to 1742 1 to 688       688/690
(99 %)
2 diff
(99.8 %id)
BF431910 pooled .a 1060 to 1605 546 to 1       546/546
(100 %)
0 diff
(100 %id)
BP292121 lung .a 1061 to 1629 1 to 569       569/569
(100 %)
1 diff
(99.9 %id)
TI_154159170   .a 1105 to 1717 91 to 702       612/669
(91 %)
44 diff
(93.5 %id)
BX349986 Neuroblastoma Cot 25-normalized .a 1132 to 2069 931 to 1       931/938
(99 %)
9 diff
(99.1 %id)
AI193102 lung .a 1144 to 1599 456 to 1       456/456
(100 %)
0 diff
(100 %id)
AI373343 Kidney .a 1147 to 1599 453 to 1       453/453
(100 %)
0 diff
(100 %id)
DB238499 trachea .a 1153 to 1762 2 to 611   capped   610/610
(100 %)
0 diff
(100 %id)
CD642257 Embryonic Stem cells .a 1216 to 2004 3 to 787       785/787
(99 %)
14 diff
(98.3 %id)
CA844301 Pancreas, Purified pancreatic islet .a 1251 to 1602 351 to 1   fully sequenced,   351/351
(100 %)
0 diff
(100 %id)
AA195262 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1256 to 1599 347 to 1   fully sequenced,   347/347
(100 %)
0 diff
(100 %id)
FN048658 breast carcinoma .a 1297 to 1368 1 to 71       71/72
(98 %)
2 diff
(97.3 %id)
EL594316 epidermis, skin .a 1361 to 2110 764 to 13     Submitted on the opposite strand 752/764
(98 %)
3 diff
(99.7 %id)
AA312553   .a 1412 to 1896 1 to 485       485/485
(100 %)
0 diff
(100 %id)
AI255026 ovary, papillary serous carcinoma .a 1456 to 1580 15 to 139     Submitted on the opposite strand 125/139
(89 %)
6 diff
(95.7 %id)
AW302031 ovary, papillary serous carcinoma .a 1456 to 1580 15 to 139     Submitted on the opposite strand 125/139
(89 %)
6 diff
(95.7 %id)
BX474591   .a 1489 to 2060 1 to 572       572/572
(100 %)
2 diff
(99.7 %id)
BP355080   .a 1496 to 2077 1 to 581       581/581
(100 %)
4 diff
(99.4 %id)
DA034164   .a 1517 to 2050 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
BC020448.
matches multiple genes
eye, Eye, retinoblastoma, retinoblastoma .a 1600 to 2999 1 to 1401   available from MGC, AAA also hits gene TJP3 1401/1401
(100 %)
3 diff
(99.8 %id)
TI_57189099   .a 1726 to 2405 48 to 724       677/677
(100 %)
3 diff
(99.6 %id)
BI858762 breast, mammary adenocarcinoma, cell line .a 1727 to 2405 1 to 676       676/676
(100 %)
3 diff
(99.6 %id)
DA216139 brain .a 1729 to 2282 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
BG575719 breast, mammary adenocarcinoma, cell line .a 1792 to 2544 1 to 753       753/753
(100 %)
0 diff
(100 %id)
AL563161 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 1848 to 2957 1096 to 1       1098/1114
(98 %)
25 diff
(97.8 %id)
AL562956 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 1888 to 2975 1077 to 1       1077/1077
(100 %)
32 diff
(97.1 %id)
BU176860 eye, retinoblastoma .a 1924 to 2845 3 to 928       926/928
(99 %)
18 diff
(98.1 %id)
BI767926 pooled lung and spleen .a 1935 to 2729 1 to 794       794/794
(100 %)
3 diff
(99.7 %id)
TI_57184017   .a 1935 to 2729 63 to 856       794/856
(92 %)
9 diff
(99.0 %id)
BI224413 cervical carcinoma cell line, cervix .a 1936 to 2620 1 to 685       685/685
(100 %)
2 diff
(99.8 %id)
BU860104 adenocarcinoma, cell line, breast .a 1965 to 2844 1 to 891       891/945
(94 %)
25 diff
(97.4 %id)
BP267712 thyroid .a 2050 to 2633 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BP267713 thyroid .a 2050 to 2633 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
BP268171 thyroid .a 2050 to 2632 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
AW406466 lymph .a 2117 to 2525 1 to 409   fully sequenced,   409/409
(100 %)
5 diff
(98.8 %id)
TI_154144042   .a 2124 to 2659 77 to 612       536/537
(99 %)
8 diff
(98.6 %id)
BG034935 adenocarcinoma, cell line, Liver .a 2126 to 2821 1 to 695       695/969
(71 %)
24 diff
(97.6 %id)
DA711636   .a 2174 to 2756 2 to 581   capped   580/580
(100 %)
3 diff
(99.5 %id)
TI_149278333   .a 2179 to 2990 893 to 89   AAA   805/1081
(74 %)
15 diff
(98.7 %id)
TI_149287726   .a 2188 to 2990 863 to 65   AAA   799/971
(82 %)
10 diff
(99.0 %id)
BU681123 lung .a 2199 to 2990 807 to 19   AAA   789/793
(99 %)
7 diff
(99.2 %id)
CA305999 Alveolar Macrophage, lung .a 2217 to 3006 803 to 19   AAA   785/787
(99 %)
7 diff
(99.2 %id)
TI_154132808   .a 2221 to 2999 888 to 99   AAA   790/806
(98 %)
25 diff
(96.9 %id)
BF036374 adenocarcinoma, ovary .a 2226 to 2984 762 to 1     Submitted on the opposite strand 762/964
(79 %)
19 diff
(98.1 %id)
BF173433 blood .a 2228 to 2377 1 to 149       149/149
(100 %)
11 diff
(92.7 %id)
BQ707360 Spleen .a 2258 to 3003 1 to 747   AAA   747/747
(100 %)
5 diff
(99.4 %id)
DA091876 cerebellum .a 2287 to 2848 2 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
BM784485 lymph node, stomach .a 2308 to 2763 1 to 456       456/456
(100 %)
0 diff
(100 %id)
DA796943 brain .a 2309 to 2841 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
BQ267544 insulinoma, Pancreas .a 2343 to 2762 8 to 427   fully sequenced,   420/427
(98 %)
6 diff
(98.6 %id)
AL044745 testis .a 2355 to 2845 1 to 491       491/491
(100 %)
0 diff
(100 %id)
AW593046 pooled .a 2357 to 3000 644 to 1       644/648
(99 %)
7 diff
(99.0 %id)
BU621838 Bone, Subchondral Bone .a 2357 to 2990 652 to 19   AAA   634/634
(100 %)
0 diff
(100 %id)
CD370522 Alveolar Macrophage, lung .a 2358 to 2994 655 to 19   AAA   637/637
(100 %)
1 diff
(99.9 %id)
BU678413 lung .a 2369 to 2990 640 to 19   AAA   622/622
(100 %)
1 diff
(99.9 %id)
BU619318 Cell Line, Chondrosarcoma .a 2369 to 2990 640 to 19   AAA   622/622
(100 %)
2 diff
(99.7 %id)
BM351918 Pancreas, Purified pancreatic islet .a 2392 to 3000 612 to 3       610/612
(99 %)
4 diff
(99.4 %id)
BQ288017 Pancreas, Purified pancreatic islet .a 2395 to 3000 608 to 3       606/608
(99 %)
1 diff
(99.9 %id)
BU932398 mixed (pool of 40 RNAs) .a 2405 to 3000 1 to 596       596/598
(99 %)
2 diff
(99.7 %id)
BJ993902 hepatoblastoma .a 2423 to 2962 540 to 1       540/540
(100 %)
0 diff
(100 %id)
AU153690   .a 2430 to 2990 559 to 1       559/569
(98 %)
4 diff
(99.3 %id)
AU131088   .a 2433 to 3253 3 to 814   capped   812/859
(94 %)
13 diff
(98.5 %id)
AA599907 bone marrow stroma .a 2434 to 2984 551 to 1       551/551
(100 %)
0 diff
(100 %id)
DA040642 bladder .a 2437 to 2989 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
AU152108   .a 2444 to 2990 547 to 1       547/547
(100 %)
12 diff
(97.9 %id)
AU152071   .a 2472 to 2990 517 to 1       517/521
(99 %)
6 diff
(98.9 %id)
AW575304 lymph .a 2495 to 2999 522 to 18   fully sequenced, AAA   505/505
(100 %)
0 diff
(100 %id)
BE302105 cervix .a 2554 to 2984 435 to 5       431/435
(99 %)
0 diff
(100 %id)
CA434864 lung, Metastatic Chondrosarcoma .a 2558 to 2996 455 to 17   AAA   439/439
(100 %)
0 diff
(100 %id)
AA612915 colon, colon tumor RER+ .a 2578 to 2662 85 to 1       85/88
(96 %)
3 diff
(96.6 %id)
DA651230   .a 2622 to 3166 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA763420 tongue .a 2682 to 3239 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BF436796 Prostate .a 2690 to 2990 301 to 1       301/301
(100 %)
0 diff
(100 %id)
BU158530 large cell carcinoma, lung .a 2711 to 3585 3 to 894       892/912
(97 %)
6 diff
(99.4 %id)
AI185459 lung .a 2718 to 2990 273 to 1       273/273
(100 %)
0 diff
(100 %id)
AI754991 bone marrow stroma .a 2724 to 2983 279 to 20   AAA   260/260
(100 %)
0 diff
(100 %id)
BQ272236 insulinoma, Pancreas .a 2732 to 2999 298 to 30   fully sequenced, AAA   269/269
(100 %)
1 diff
(99.7 %id)
AW248919 lung, small cell carcinoma .a 2745 to 2990 256 to 11   AAA   246/246
(100 %)
0 diff
(100 %id)
AU279539   .a 2864 to 3398 1 to 535       535/535
(100 %)
0 diff
(100 %id)
AI468931 lymph node, lymphoma, follicular mixed small and largecell .a 2864 to 2990 149 to 23   AAA   127/127
(100 %)
0 diff
(100 %id)
BM784507 lymph node, stomach .a 2869 to 2999 1 to 131   AAA   131/131
(100 %)
0 diff
(100 %id)
BM710647 eye, fetal eyes .a 2923 to 3189 1 to 267       267/267
(100 %)
1 diff
(99.7 %id)
DA166955 amygdala .a 2939 to 3500 2 to 567   tiling clone, capped   566/566
(100 %)
2 diff
(99.7 %id)
DA696862   .a 2963 to 3529 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA152318 amygdala .a 3000 to 3533 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
DA359396 subthalamic nucleus .a 3020 to 3308 2 to 290   capped   289/289
(100 %)
0 diff
(100 %id)
BJ995216 hepatoblastoma .a 3066 to 3588 1 to 523       523/523
(100 %)
0 diff
(100 %id)
DA715045   .a 3132 to 3663 2 to 533   tiling clone, capped   532/532
(100 %)
0 diff
(100 %id)
BX374479 Neuroblastoma Cot 10-normalized .a 3418 to 4419 1 to 992       992/992
(100 %)
18 diff
(98.2 %id)
AF070554 brain .a 3502 to 4923 11 to 1433   tiling clone, AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 1423/1433
(99 %)
7 diff
(99.6 %id)
AI436123 Kidney .a 3610 to 4081 1 to 472       472/472
(100 %)
0 diff
(100 %id)
EL948139 eyeball .a 3625 to 4292 1 to 665   tiling clone,   665/665
(100 %)
8 diff
(98.8 %id)
DB323309   .a 4413 to 4934 522 to 1       522/522
(100 %)
1 diff
(99.9 %id)
DB368188   .a 4631 to 5152 521 to 1       521/562
(92 %)
5 diff
(99.2 %id)
BM667367 eye, fetal eyes .a 4637 to 5152 534 to 19   tiling clone, AAA   516/516
(100 %)
0 diff
(100 %id)
BJ995217 hepatoblastoma .a 4677 to 5118 442 to 1       442/442
(100 %)
0 diff
(100 %id)
DA864433 placenta .b 1 to 591 2 to 593 V56C R57Q S58I F59L G60W ... tiling clone, capped   592/592
(100 %)
1 diff
(99.9 %id)
EC490682 Prostate .b 13 to 99 1 to 87       87/87
(100 %)
0 diff
(100 %id)
EC504669 Prostate .b 13 to 99 1 to 87       87/87
(100 %)
0 diff
(100 %id)
AA215907   .b 20 to 298 1 to 280       280/280
(100 %)
3 diff
(99.0 %id)
BF170182 blood .b 20 to 261 1 to 242       242/242
(100 %)
8 diff
(96.7 %id)
EC479961 Prostate .b 20 to 111 1 to 92       92/92
(100 %)
0 diff
(100 %id)
EC518834 Prostate .b 20 to 111 1 to 92       92/92
(100 %)
0 diff
(100 %id)
R83796 breast .b 20 to 278 1 to 259       259/259
(100 %)
1 diff
(99.7 %id)
N86132   .b 20 to 372 1 to 354       354/354
(100 %)
5 diff
(98.6 %id)
AA092904   .b 21 to 263 1 to 239       239/239
(100 %)
9 diff
(96.3 %id)
AA095716   .b 21 to 253 1 to 234       234/234
(100 %)
10 diff
(95.8 %id)
AA248239   .b 21 to 319 1 to 300       300/300
(100 %)
4 diff
(98.7 %id)
EC450686 Prostate .b 21 to 111 1 to 93       93/93
(100 %)
2 diff
(97.9 %id)
EC470234 Prostate .b 21 to 111 1 to 91       91/91
(100 %)
0 diff
(100 %id)
EC494509 Prostate .b 21 to 111 1 to 91       91/91
(100 %)
2 diff
(97.9 %id)
EC494822 Prostate .b 21 to 111 1 to 90       90/90
(100 %)
3 diff
(96.7 %id)
EC581540 Prostate .b 21 to 111 1 to 90       90/90
(100 %)
3 diff
(96.7 %id)
W16676 lung .b 21 to 129 1 to 109       109/109
(100 %)
2 diff
(98.2 %id)
AA579132   .b 21 to 412 1 to 393       393/400
(98 %)
10 diff
(97.5 %id)
N86107   .b 21 to 280 1 to 262       262/305
(85 %)
4 diff
(98.7 %id)
CB123727 Liver .b 21 to 412 1 to 392       392/399
(98 %)
3 diff
(99.3 %id)
AA092347   .b 22 to 203 1 to 182       182/182
(100 %)
4 diff
(97.9 %id)
BE018539 cervix .b 22 to 359 1 to 338   fully sequenced,   338/338
(100 %)
0 diff
(100 %id)
BE018548 cervix .b 22 to 359 1 to 338   fully sequenced,   338/338
(100 %)
0 diff
(100 %id)
D54524   .b 23 to 393 1 to 368       368/368
(100 %)
5 diff
(98.7 %id)
D55948   .b 23 to 322 1 to 297       297/297
(100 %)
4 diff
(98.7 %id)
AA216252   .b 24 to 243 1 to 220       220/220
(100 %)
1 diff
(99.6 %id)
AA094181   .b 25 to 278 1 to 252       252/310
(81 %)
7 diff
(97.8 %id)
AA354808   .b 25 to 386 1 to 371       369/406
(90 %)
10 diff
(97.6 %id)
AA385384 thyroid gland .b 25 to 286 1 to 262       262/262
(100 %)
1 diff
(99.7 %id)
BF174176 blood .b 25 to 199 1 to 177       177/178
(99 %)
11 diff
(93.9 %id)
N83351   .b 25 to 281 1 to 252       252/255
(98 %)
6 diff
(97.7 %id)
C14969   .b 27 to 340 1 to 313       313/318
(98 %)
1 diff
(99.7 %id)
D52222   .b 27 to 264 1 to 238       238/238
(100 %)
1 diff
(99.6 %id)
N88777   .b 28 to 281 1 to 253       253/262
(96 %)
3 diff
(98.9 %id)
AJ714192 bone marrow .b 29 to 339 1 to 309       309/309
(100 %)
2 diff
(99.4 %id)
EC540857 Prostate .b 29 to 131 1 to 101       101/101
(100 %)
6 diff
(94.1 %id)
AI491898 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 29 to 358 330 to 1       330/334
(98 %)
5 diff
(98.6 %id)
CN269181 embryonic stem cells, DMSO-treated H9 cellline .b 30 to 329 1 to 300       300/300
(100 %)
0 diff
(100 %id)
DW423973 Liver .b 30 to 306 14 to 290       277/290
(95 %)
6 diff
(98.0 %id)
H28310 breast .b 30 to 394 14 to 381       368/382
(96 %)
13 diff
(96.6 %id)
AW166845 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 30 to 358 329 to 1       329/329
(100 %)
2 diff
(99.4 %id)
AW404604 lymph .b 30 to 340 1 to 311       311/311
(100 %)
6 diff
(98.1 %id)
AJ714031 bone marrow .b 31 to 346 1 to 315       315/315
(100 %)
2 diff
(99.4 %id)
ES311856 frontal balding hair, skin .b 31 to 230 1 to 200       200/202
(99 %)
2 diff
(99.1 %id)
ES311893 frontal balding hair, skin .b 31 to 281 1 to 250       250/257
(97 %)
2 diff
(99.3 %id)
N85578   .b 31 to 334 1 to 300       300/302
(99 %)
3 diff
(99.1 %id)
N87863   .b 31 to 203 1 to 172       172/173
(99 %)
2 diff
(98.9 %id)
AA362787 ovary .b 32 to 393 1 to 363       363/363
(100 %)
4 diff
(98.9 %id)
EC551608 Prostate .b 32 to 135 1 to 103       103/103
(100 %)
3 diff
(97.1 %id)
AW405865 lymph .b 32 to 340 1 to 309       309/309
(100 %)
5 diff
(98.4 %id)
BF173459 blood .b 33 to 411 1 to 379       379/381
(99 %)
4 diff
(99.0 %id)
CN269219 embryonic stem cells, DMSO-treated H9 cellline .b 33 to 305 1 to 273       273/273
(100 %)
0 diff
(100 %id)
W00923 liver and spleen .b 33 to 376 1 to 348       348/348
(100 %)
9 diff
(97.5 %id)
AA316027 colon .b 34 to 329 1 to 296       296/298
(99 %)
1 diff
(99.7 %id)
BM704347 eye, Retina Foveal and Macular .b 34 to 376 22 to 364       343/364
(94 %)
9 diff
(97.6 %id)
AJ713349 bone marrow .b 35 to 350 22 to 336       315/336
(93 %)
7 diff
(98.0 %id)
AA187804   .b 35 to 165 1 to 131       131/132
(99 %)
1 diff
(99.3 %id)
AI572872 lymph node, lymphoma, follicular mixed small and largecell .b 35 to 358 322 to 1       322/322
(100 %)
8 diff
(97.6 %id)
AI628020 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .b 35 to 358 321 to 1       321/321
(100 %)
5 diff
(98.5 %id)
CN269153 embryonic stem cells, DMSO-treated H9 cellline .b 36 to 238 1 to 203       203/203
(100 %)
0 diff
(100 %id)
AW148810 brain, tumor, 5 pooled (see description) .b 36 to 356 322 to 2       321/322
(99 %)
4 diff
(98.8 %id)
BF000828 malignant melanoma, metastatic to lymphnode, skin .b 36 to 358 324 to 1       324/324
(100 %)
3 diff
(99.1 %id)
EC545049 Prostate .b 37 to 137 1 to 101       101/101
(100 %)
4 diff
(96.1 %id)
AA090195   .b 38 to 207 1 to 166       166/166
(100 %)
4 diff
(97.6 %id)
AA320435 adipose tissue, white .b 38 to 342 1 to 309       309/310
(99 %)
7 diff
(97.8 %id)
EC485060 Prostate .b 38 to 137 1 to 100       100/100
(100 %)
3 diff
(97.0 %id)
AI683962 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 39 to 358 320 to 1       320/321
(99 %)
11 diff
(96.6 %id)
AW407931 lymph .b 39 to 249 1 to 211       211/211
(100 %)
12 diff
(94.4 %id)
AA312477   .b 41 to 372 1 to 334       334/334
(100 %)
3 diff
(99.2 %id)
AA373946 lung .b 41 to 310 1 to 270       270/271
(99 %)
3 diff
(98.9 %id)
CN269189 embryonic stem cells, DMSO-treated H9 cellline .b 44 to 407 1 to 364       364/364
(100 %)
0 diff
(100 %id)
EC507430 Prostate .b 44 to 138 1 to 96       96/96
(100 %)
2 diff
(98.0 %id)
AI587312 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .b 44 to 358 314 to 1       314/323
(97 %)
2 diff
(99.4 %id)
FN082233 breast carcinoma .b 45 to 140 1 to 96       96/96
(100 %)
1 diff
(99.0 %id)
AW275989 lung, two pooled squamous cell carcinomas .b 45 to 358 314 to 1       314/314
(100 %)
0 diff
(100 %id)
CN269231 embryonic stem cells, DMSO-treated H9 cellline .b 47 to 248 1 to 202       202/202
(100 %)
0 diff
(100 %id)
BJ997049 hepatoblastoma .b 48 to 412 10 to 374       365/426
(85 %)
13 diff
(97.0 %id)
AW193561 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 48 to 358 311 to 1       311/311
(100 %)
0 diff
(100 %id)
BG576899 breast, mammary adenocarcinoma, cell line .b 48 to 371 1 to 330       330/332
(99 %)
11 diff
(96.7 %id)
AA385576 thyroid gland .b 51 to 298 1 to 248       248/255
(97 %)
3 diff
(98.9 %id)
D55883   .b 51 to 345 1 to 295       295/295
(100 %)
5 diff
(98.4 %id)
AA299741 uterus .b 52 to 310 1 to 263       263/263
(100 %)
6 diff
(97.8 %id)
AA301917 aorta .b 52 to 280 1 to 230       230/230
(100 %)
2 diff
(99.2 %id)
AA305246 aorta .b 52 to 274 1 to 223       223/223
(100 %)
2 diff
(99.2 %id)
AA305952   .b 52 to 299 1 to 248       248/256
(96 %)
1 diff
(99.7 %id)
AA310136   .b 52 to 302 1 to 253       251/253
(99 %)
3 diff
(98.9 %id)
AA318205 retina .b 52 to 388 1 to 338       338/338
(100 %)
13 diff
(96.2 %id)
AA320126 adipose tissue, white .b 52 to 322 1 to 271       271/271
(100 %)
2 diff
(99.3 %id)
AA320658 adipose tissue, white .b 52 to 371 1 to 323       323/323
(100 %)
12 diff
(96.3 %id)
AA321045 adipose tissue, white .b 52 to 298 1 to 247       247/249
(99 %)
3 diff
(98.8 %id)
AA330046   .b 52 to 399 1 to 352       352/354
(99 %)
8 diff
(97.8 %id)
AA331958 Embryo, 8 weeks .b 52 to 377 1 to 330       330/330
(100 %)
5 diff
(98.5 %id)
AA332869 Embryo, 8 weeks .b 52 to 325 1 to 275       275/276
(99 %)
4 diff
(98.6 %id)
AA345264 gall bladder .b 52 to 214 1 to 163       163/163
(100 %)
3 diff
(98.2 %id)
AA348076 heart .b 52 to 280 1 to 230       230/273
(84 %)
4 diff
(98.6 %id)
AA359299 lung .b 52 to 291 1 to 240       240/240
(100 %)
0 diff
(100 %id)
AA369445 placenta .b 52 to 262 1 to 211       211/211
(100 %)
2 diff
(99.1 %id)
AA369657 placenta .b 52 to 281 1 to 231       231/235
(98 %)
2 diff
(99.2 %id)
AA370117 Prostate .b 52 to 342 1 to 295       295/295
(100 %)
6 diff
(98.0 %id)
AA375237 lung .b 52 to 406 1 to 364       362/364
(99 %)
12 diff
(96.8 %id)
AA379116 skin .b 52 to 223 1 to 172       172/172
(100 %)
1 diff
(99.5 %id)
AA382864 testis .b 52 to 292 1 to 241       241/241
(100 %)
2 diff
(99.2 %id)
AI589377 adenocarcinoma, Pancreas .b 52 to 358 307 to 1       307/323
(95 %)
7 diff
(97.9 %id)
AI569447 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 53 to 358 307 to 1       307/308
(99 %)
17 diff
(94.5 %id)
AI708095 colon .b 53 to 108 56 to 1       56/61
(91 %)
0 diff
(100 %id)
AI283339 ovary, tumor, 5 pooled (see description) .b 54 to 358 305 to 1       305/305
(100 %)
2 diff
(99.4 %id)
AI633028 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 54 to 358 305 to 1       305/305
(100 %)
0 diff
(100 %id)
EC528106 Prostate .b 60 to 148 1 to 89       89/89
(100 %)
0 diff
(100 %id)
AW304115 lung, two pooled squamous cell carcinomas .b 60 to 358 302 to 1       302/302
(100 %)
9 diff
(97.1 %id)
AA377080 small intestine .b 61 to 291 1 to 231       231/231
(100 %)
0 diff
(100 %id)
AA382412 testis .b 61 to 235 1 to 175       175/175
(100 %)
2 diff
(98.9 %id)
CN269205 embryonic stem cells, DMSO-treated H9 cellline .b 63 to 243 1 to 181       181/181
(100 %)
0 diff
(100 %id)
AI499273 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 63 to 357 295 to 1       295/295
(100 %)
4 diff
(98.7 %id)
AW131044 Kidney, renal cell tumor .b 66 to 358 293 to 1       293/293
(100 %)
5 diff
(98.3 %id)
BQ326165 colon_normal .b 68 to 412 353 to 8       344/353
(97 %)
5 diff
(98.6 %id)
AW513631 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 68 to 356 289 to 2       288/289
(99 %)
6 diff
(98.0 %id)
AI191717   .b 69 to 408 340 to 1       340/340
(100 %)
3 diff
(99.2 %id)
AW468949 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 69 to 358 277 to 1       277/297
(93 %)
21 diff
(93.0 %id)
CA946366 eye, lacrimal gland .b 78 to 199 122 to 1     Submitted on the opposite strand 122/122
(100 %)
0 diff
(100 %id)
AA335026   .b 79 to 354 1 to 276       276/277
(99 %)
4 diff
(98.6 %id)
CN269197 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 85 to 359 1 to 275       275/275
(100 %)
0 diff
(100 %id)
DW414031 Liver .b 90 to 390 17 to 317       301/317
(94 %)
7 diff
(97.8 %id)
EC493883 Prostate .b 91 to 187 1 to 96       96/96
(100 %)
6 diff
(93.8 %id)
AW841233 colon_normal .b 92 to 275 3 to 188       186/190
(97 %)
7 diff
(96.4 %id)
EC516934 Prostate .b 92 to 187 1 to 96       96/96
(100 %)
7 diff
(92.8 %id)
AW058386 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 93 to 356 266 to 3       264/269
(98 %)
1 diff
(99.7 %id)
AI640383 adenocarcinoma, Pancreas .b 96 to 358 263 to 1       263/263
(100 %)
2 diff
(99.3 %id)
AI640398 adenocarcinoma, Pancreas .b 96 to 358 264 to 1       264/264
(100 %)
6 diff
(97.8 %id)
AA581297 bulk alveolar tumor .b 105 to 169 64 to 1       64/64
(100 %)
1 diff
(98.5 %id)
BQ376772 uterus .b 110 to 412 1 to 302   tiling clone,   302/315
(95 %)
7 diff
(97.8 %id)
AA295948 thymus .b 111 to 375 1 to 265       265/265
(100 %)
2 diff
(99.3 %id)
CN269246 embryonic stem cells, DMSO-treated H9 cellline .b 112 to 391 1 to 280       280/280
(100 %)
0 diff
(100 %id)
BQ376775 uterus .b 115 to 412 1 to 299       299/312
(95 %)
8 diff
(97.5 %id)
AA664691 alveolar rhabdomyosarcoma .b 116 to 387 1 to 272       272/272
(100 %)
1 diff
(99.7 %id)
BQ319073 colon .b 117 to 352 245 to 10       236/245
(96 %)
0 diff
(100 %id)
BQ376774 uterus .b 117 to 412 10 to 304       295/318
(92 %)
8 diff
(97.5 %id)
BE166000 head_neck .b 122 to 219 8 to 105       98/105
(93 %)
6 diff
(94.3 %id)
N57228 placenta .b 122 to 411 1 to 293       293/316
(92 %)
4 diff
(98.8 %id)
AI434584 lymph node, lymphoma, follicular mixed small and largecell .b 124 to 357 234 to 1       234/241
(97 %)
1 diff
(99.6 %id)
AW591648 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 132 to 356 229 to 3       227/229
(99 %)
6 diff
(97.4 %id)
BQ376741 uterus .b 133 to 412 1 to 279       279/293
(95 %)
6 diff
(98.0 %id)
DW430840 Liver .b 134 to 391 14 to 271       258/271
(95 %)
7 diff
(97.5 %id)
EH331646   .b 138 to 216 1 to 78       78/78
(100 %)
1 diff
(98.8 %id)
BQ310916 breast_normal .b 141 to 385 1 to 246       246/246
(100 %)
4 diff
(98.4 %id)
BE302135 cervix .b 141 to 358 218 to 1   fully sequenced,   218/218
(100 %)
0 diff
(100 %id)
BE302144 cervix .b 141 to 358 218 to 1   fully sequenced,   218/218
(100 %)
0 diff
(100 %id)
AA894883 metastatic prostate bone lesion .b 146 to 339 1 to 196       196/201
(97 %)
13 diff
(93.6 %id)
AA657836   .b 147 to 367 1 to 221       221/222
(99 %)
4 diff
(98.2 %id)
BQ376771 uterus .b 167 to 412 1 to 246       246/260
(94 %)
4 diff
(98.5 %id)
EC547710 Prostate .b 172 to 251 1 to 78       78/91
(85 %)
2 diff
(97.9 %id)
AA886816 metastatic prostate bone lesion .b 179 to 305 1 to 127       127/127
(100 %)
6 diff
(95.3 %id)
AI613298 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 180 to 358 179 to 1       179/179
(100 %)
0 diff
(100 %id)
AI433363 lymph node, lymphoma, follicular mixed small and largecell .b 183 to 357 175 to 1       175/175
(100 %)
8 diff
(95.5 %id)
AW192977 adenocarcinoma, Pancreas .b 183 to 358 171 to 1       171/202
(84 %)
14 diff
(93.1 %id)
AI469434 colon, moderately-differentiated adenocarcinoma .b 190 to 358 169 to 1       169/169
(100 %)
0 diff
(100 %id)
EC495098 Prostate .b 195 to 303 112 to 5       108/112
(96 %)
1 diff
(99.2 %id)
BQ325991 colon_ins .b 197 to 410 248 to 33       216/248
(87 %)
15 diff
(94.0 %id)
AA581035 bulk germ cell seminoma .b 204 to 361 1 to 158       158/159
(99 %)
3 diff
(98.2 %id)
EC484129 Prostate .b 211 to 319 1 to 109       109/109
(100 %)
3 diff
(97.3 %id)
CN269175 embryonic stem cells, DMSO-treated H9 cellline .b 225 to 407 1 to 183       183/183
(100 %)
1 diff
(99.5 %id)
BQ371351 prostate_normal .b 230 to 410 183 to 3       181/183
(98 %)
0 diff
(100 %id)
BX282923 normal prostate, Prostate .b 244 to 398 1 to 155       155/160
(96 %)
1 diff
(99.4 %id)
CR740386 normal prostate, Prostate .b 244 to 398 1 to 155       155/160
(96 %)
1 diff
(99.4 %id)
F35455 pectoral muscle (after mastectomy) .b 246 to 399 1 to 154       154/154
(100 %)
6 diff
(96.2 %id)
EC507306 Prostate .b 275 to 387 1 to 111       111/111
(100 %)
3 diff
(97.3 %id)
EC534604 Prostate .b 275 to 387 1 to 111       111/111
(100 %)
5 diff
(95.5 %id)
BE938817 testis_normal .b 276 to 412 143 to 7       137/143
(95 %)
0 diff
(100 %id)
EC520127 Prostate .b 277 to 387 3 to 108       106/108
(98 %)
6 diff
(94.5 %id)
EC490043 Prostate .b 283 to 396 1 to 113       113/113
(100 %)
1 diff
(99.2 %id)
EC455585 Prostate .b 292 to 404 1 to 113       113/113
(100 %)
0 diff
(100 %id)
BP236096 coronary artery .c 1 to 581 2 to 582 exact tiling clone,   587/587
(100 %)
0 diff
(100 %id)
BJ991936 hepatoblastoma .c 1 to 522 2 to 523       523/523
(100 %)
0 diff
(100 %id)
DA660101   .c 1 to 572 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DB477609 hippocampus .c 3 to 484 1 to 482       482/482
(100 %)
0 diff
(100 %id)
DB479804 hippocampus .c 3 to 509 1 to 507       507/507
(100 %)
0 diff
(100 %id)
EL946341 eyeball .c 10 to 467 1 to 458       458/458
(100 %)
7 diff
(98.5 %id)
CD673573 eye, lens .c 13 to 423 1 to 411   fully sequenced,   411/411
(100 %)
0 diff
(100 %id)
ES313844 beard hair, skin .c 23 to 523 1 to 499       499/549
(90 %)
7 diff
(98.8 %id)
BX405163 T cells (Jurkat cell line) .c 24 to 522 1 to 499   fully sequenced,   499/499
(100 %)
0 diff
(100 %id)
ES313835 beard hair, skin .c 24 to 523 1 to 499       499/534
(93 %)
5 diff
(99.1 %id)
TI_57163265   .c 26 to 503 41 to 519       479/521
(91 %)
8 diff
(98.5 %id)
TI_57188124   .c 27 to 516 69 to 574       503/522
(96 %)
13 diff
(97.6 %id)
TI_154141576   .c 40 to 504 91 to 555   AAA   465/476
(97 %)
21 diff
(95.6 %id)
TI_154143623   .c 63 to 524 80 to 540       461/548
(84 %)
4 diff
(99.3 %id)
BE165992 head_neck .c 93 to 488 1 to 409       407/410
(99 %)
28 diff
(93.2 %id)
CD673572 eye, lens .c 144 to 415 280 to 9   fully sequenced,   272/280
(97 %)
0 diff
(100 %id)
T58458 ovary .c 145 to 526 1 to 385       385/454
(84 %)
7 diff
(98.5 %id)
AW772600 normal epithelium, thyroid .c 178 to 524 375 to 26       351/403
(87 %)
26 diff
(93.6 %id)
FN089348 breast carcinoma .c 355 to 450 100 to 1     Submitted on the opposite strand 100/100
(100 %)
12 diff
(88.0 %id)
EC456741 Prostate .c 356 to 446 1 to 94       94/94
(100 %)
1 diff
(99.0 %id)
EC505407 Prostate .c 356 to 454 1 to 99       99/99
(100 %)
2 diff
(98.0 %id)
EC572419 Prostate .c 358 to 444 21 to 106       86/106
(81 %)
7 diff
(93.4 %id)
BQ292164 amnion_normal .c 365 to 458 117 to 24       94/117
(80 %)
2 diff
(98.3 %id)
EC506531 Prostate .c 368 to 463 1 to 96       96/96
(100 %)
0 diff
(100 %id)
EC579524 Prostate .c 368 to 463 1 to 96       96/96
(100 %)
0 diff
(100 %id)
BE071832 breast .c 373 to 500 146 to 19     Submitted on the opposite strand 128/146
(87 %)
0 diff
(100 %id)
BE934844 leiomios .c 373 to 500 144 to 17       128/144
(88 %)
1 diff
(99.4 %id)
BX405162 T cells (Jurkat cell line) .c 447 to 524 78 to 1   fully sequenced,   78/78
(100 %)
0 diff
(100 %id)
BP280989   .d 1 to 576 1 to 577 exact tiling clone,   582/582
(100 %)
3 diff
(99.5 %id)
BF092758 testis_normal .d 4 to 223 12 to 232       221/242
(91 %)
14 diff
(94.3 %id)
CN269229 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 10 to 285 12 to 287   tiling clone,   276/287
(96 %)
6 diff
(98.0 %id)
EC453932 Prostate .d 12 to 97 1 to 85       85/88
(96 %)
2 diff
(97.8 %id)
EC511135 Prostate .d 12 to 97 1 to 85       85/88
(96 %)
2 diff
(97.8 %id)
EC564942 Prostate .d 14 to 101 1 to 85       85/85
(100 %)
3 diff
(96.5 %id)
CD673798 eye, lens .d 15 to 394 1 to 380       380/380
(100 %)
7 diff
(98.2 %id)
BM844272 lymph node, stomach .d 16 to 134 1 to 119       119/119
(100 %)
9 diff
(92.5 %id)
EC560034 Prostate .d 17 to 113 1 to 97       97/97
(100 %)
5 diff
(94.9 %id)
EC451850 Prostate .d 18 to 113 1 to 93       93/93
(100 %)
5 diff
(94.7 %id)
EC468056 Prostate .d 18 to 101 10 to 93       84/93
(90 %)
6 diff
(93.6 %id)
EC489927 Prostate .d 18 to 101 8 to 89       82/89
(92 %)
6 diff
(93.3 %id)
EC549445 Prostate .d 18 to 101 8 to 88       81/88
(92 %)
6 diff
(93.2 %id)
EC555476 Prostate .d 22 to 101 11 to 89       79/89
(88 %)
6 diff
(93.3 %id)
AW386228 pnet .d 27 to 278 254 to 1       252/259
(97 %)
11 diff
(95.8 %id)
BG108025 Bone, osteosarcoma, cell line .e 1 to 610 2 to 611 exact tiling clone,   611/627
(97 %)
1 diff
(99.9 %id)
CB851146 lung, Primary Lung Epithelial Cells .e 6 to 582 2 to 578 K159X K178X   Submitted on the opposite strand 577/578
(99 %)
6 diff
(99.0 %id)
AK311816 amygdala .e 7 to 566 1 to 560 exact     560/560
(100 %)
2 diff
(99.7 %id)
BF095105 uterus_tumor .e 7 to 217 220 to 10       211/231
(91 %)
10 diff
(95.7 %id)
TI_149277006   .e 7 to 613 49 to 656 G27E   Submitted on the opposite strand 608/1079
(56 %)
12 diff
(98.9 %id)
TI_149305082   .e 7 to 608 46 to 648 K159X K178X   Submitted on the opposite strand 603/652
(92 %)
7 diff
(99.0 %id)
TI_159700006   .e 7 to 608 44 to 646 K159X K178X AAA Submitted on the opposite strand 603/646
(93 %)
6 diff
(99.1 %id)
NM_000975.2   .e 10 to 618 1 to 609 exact RefSeq,   609/609
(100 %)
0 diff
(100 %id)
BG700016 brain, hippocampus .e 11 to 616 7 to 612 exact AAA   606/612
(99 %)
7 diff
(98.9 %id)
BG699800 brain, hippocampus .e 11 to 616 7 to 612 exact AAA   606/612
(99 %)
7 diff
(98.9 %id)
CB129354 cervix, Uterine .e 12 to 614 1 to 603 exact     603/603
(100 %)
0 diff
(100 %id)
CB152422 cervix, Uterine .e 12 to 579 1 to 568 exact     568/568
(100 %)
0 diff
(100 %id)
BP212134 cerebrum .e 12 to 593 1 to 582 exact     582/582
(100 %)
0 diff
(100 %id)
TI_45212173   .e 12 to 616 92 to 696 exact AAA   605/696
(86 %)
6 diff
(99.2 %id)
TI_44345466   .e 12 to 615 123 to 726 exact tiling clone, AAA   604/726
(83 %)
6 diff
(99.2 %id)
TI_44346084   .e 12 to 615 91 to 694 exact AAA   604/694
(87 %)
6 diff
(99.2 %id)
CB124301 Liver .e 12 to 608 1 to 597 exact     597/597
(100 %)
0 diff
(100 %id)
BP288893 lung .e 12 to 581 1 to 570 exact     570/570
(100 %)
0 diff
(100 %id)
BP301813   .e 12 to 592 1 to 581 K178X     581/581
(100 %)
0 diff
(100 %id)
BM740317 Ascites, stomach .e 12 to 608 1 to 597 exact AAA   597/597
(100 %)
0 diff
(100 %id)
BM787191 Ascites, stomach .e 12 to 603 1 to 592 exact     592/592
(100 %)
0 diff
(100 %id)
BM787196 Ascites, stomach .e 12 to 607 1 to 596 exact     596/596
(100 %)
0 diff
(100 %id)
BM840742 lymph node, stomach .e 12 to 580 1 to 569 exact     569/569
(100 %)
0 diff
(100 %id)
BM840711 lymph node, stomach .e 12 to 603 1 to 592 exact     592/592
(100 %)
0 diff
(100 %id)
BM842116 lymph node, stomach .e 12 to 579 1 to 568 exact     568/568
(100 %)
0 diff
(100 %id)
BM843053 lymph node, stomach .e 12 to 608 1 to 597 exact AAA   597/597
(100 %)
0 diff
(100 %id)
BM781859 myeloma .e 12 to 607 1 to 596 exact     596/596
(100 %)
0 diff
(100 %id)
BM766985 stomach .e 12 to 603 1 to 592 exact     592/592
(100 %)
0 diff
(100 %id)
BM783187 stomach .e 12 to 579 1 to 568 exact     568/568
(100 %)
0 diff
(100 %id)
BM789936 stomach .e 12 to 607 1 to 596 exact     596/596
(100 %)
0 diff
(100 %id)
DA069386 cerebellum .e 13 to 587 2 to 576 exact capped   575/575
(100 %)
0 diff
(100 %id)
DA071060 cerebellum .e 13 to 582 2 to 571 exact capped   570/570
(100 %)
0 diff
(100 %id)
DA443970 tongue, tumor tissue .e 13 to 590 2 to 579 exact capped   578/578
(100 %)
0 diff
(100 %id)
DA513756 brain .e 13 to 585 2 to 574 exact capped   573/573
(100 %)
0 diff
(100 %id)
DA529750 brain .e 13 to 608 2 to 597 exact capped, AAA   596/596
(100 %)
0 diff
(100 %id)
DA570837 whole embryo, mainly head .e 13 to 608 2 to 597 K19E fully sequenced, capped   596/596
(100 %)
1 diff
(99.9 %id)
DA908635   .e 13 to 583 2 to 572 exact capped   571/571
(100 %)
0 diff
(100 %id)
DA933474 Spleen .e 13 to 586 2 to 575 exact capped   574/574
(100 %)
0 diff
(100 %id)
DB106066 thymus .e 13 to 588 2 to 577 exact capped   576/576
(100 %)
0 diff
(100 %id)
DB119154 thymus .e 13 to 580 2 to 569 exact capped   568/568
(100 %)
0 diff
(100 %id)
CN269213 embryonic stem cells, cell lines H1, H7, andH9 .e 17 to 608 2 to 593 exact AAA   592/593
(99 %)
6 diff
(99.0 %id)
BY795007 eye .e 19 to 617 1 to 599 exact     599/599
(100 %)
0 diff
(100 %id)
CN269182 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 20 to 608 1 to 589 exact AAA   589/589
(100 %)
6 diff
(99.0 %id)
BQ631806 Pancreas, Purified pancreatic islet .e 20 to 456 4 to 440   fully sequenced,   437/440
(99 %)
6 diff
(98.7 %id)
BU169361 eye, retinoblastoma .e 20 to 616 5 to 601 exact AAA   597/601
(99 %)
6 diff
(99.1 %id)
BU902342 leiomyosarcoma, uterus .e 20 to 608 5 to 593 exact AAA   589/593
(99 %)
6 diff
(99.0 %id)
CD513997 brain, Pituitary .e 21 to 618 19 to 616 exact     598/653
(91 %)
10 diff
(98.5 %id)
BM016380 breast, mammary adenocarcinoma, cell line .e 22 to 608 11 to 597 I123X AAA   587/597
(98 %)
6 diff
(99.0 %id)
BM478110 lymph, lymphoma, cell line .e 22 to 618 31 to 627 exact     597/1139
(52 %)
12 diff
(99.0 %id)
BU159129 eye, retinoblastoma .e 22 to 608 1 to 587 exact AAA   587/587
(100 %)
0 diff
(100 %id)
TI_59394796   .e 22 to 618 94 to 690 I123X AAA   597/823
(72 %)
11 diff
(98.7 %id)
BI856419 breast, mammary adenocarcinoma, cell line .e 23 to 616 1 to 594 exact AAA   594/594
(100 %)
0 diff
(100 %id)
TI_57190389   .e 23 to 616 59 to 652 exact AAA   594/594
(100 %)
0 diff
(100 %id)
BM466407 eye, retinoblastoma .e 24 to 615 62 to 653   AAA   592/653
(90 %)
6 diff
(99.1 %id)
BQ422822 embryonal carcinoma, cell line, testis .e 24 to 608 1 to 585 exact AAA   585/585
(100 %)
0 diff
(100 %id)
TI_57148560   .e 24 to 611 68 to 657       590/914
(64 %)
7 diff
(99.3 %id)
TI_57174083   .e 24 to 608 28 to 612 exact AAA   585/612
(95 %)
0 diff
(100 %id)
CN269180 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 25 to 608 1 to 584 exact AAA   584/584
(100 %)
0 diff
(100 %id)
CN269204 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 25 to 608 8 to 591 exact AAA   584/591
(98 %)
0 diff
(100 %id)
BG030681 breast, mammary adenocarcinoma, cell line .e 25 to 608 1 to 584 exact AAA   584/584
(100 %)
0 diff
(100 %id)
BG388844 embryonal carcinoma, cell line, testis .e 25 to 608 1 to 584 exact AAA   584/584
(100 %)
0 diff
(100 %id)
BI825928 brain, medulla .e 25 to 608 1 to 584 exact AAA   584/584
(100 %)
0 diff
(100 %id)
BM471997 eye, retinoblastoma .e 25 to 608 1 to 584 exact AAA   584/584
(100 %)
0 diff
(100 %id)
BQ430174 large cell carcinoma, lung .e 25 to 618 24 to 617 exact     594/618
(96 %)
1 diff
(99.9 %id)
TI_59391710   .e 25 to 610 87 to 679 R95K N97K N98Q F99L S100L ...     593/908
(65 %)
13 diff
(98.6 %id)
BM552222 astrocytoma grade IV, cell line, brain .e 26 to 616 21 to 611 exact AAA   591/611
(96 %)
0 diff
(100 %id)
BM801930 eye, retinoblastoma .e 26 to 608 1 to 583 exact AAA   583/583
(100 %)
0 diff
(100 %id)
BQ215620 large cell carcinoma, lung .e 26 to 616 1 to 591 exact AAA   591/591
(100 %)
0 diff
(100 %id)
BQ425530 eye, retinoblastoma .e 26 to 608 1 to 583 exact AAA   583/583
(100 %)
0 diff
(100 %id)
CB157343 Liver .e 26 to 615 1 to 590 exact     590/590
(100 %)
0 diff
(100 %id)
BM787338 Ascites, stomach .e 26 to 607 1 to 582 K159X     582/582
(100 %)
0 diff
(100 %id)
CD678556 eye, Trabecular meshwork .e 27 to 608 1 to 582 exact AAA   582/582
(100 %)
0 diff
(100 %id)
W04914 lung .e 27 to 374 1 to 347   fully sequenced,   347/347
(100 %)
0 diff
(100 %id)
BG403432 bladder, transitional cell papilloma, cell line .e 27 to 616 1 to 590 F107X AAA   590/590
(100 %)
0 diff
(100 %id)
BI828609 brain, medulla .e 27 to 615 1 to 589 exact AAA   589/589
(100 %)
0 diff
(100 %id)
BM014393 breast, mammary adenocarcinoma, cell line .e 27 to 608 1 to 582 exact AAA   582/582
(100 %)
0 diff
(100 %id)
TI_57150938   .e 27 to 604 68 to 646 exact     579/800
(72 %)
7 diff
(99.2 %id)
TI_57175308   .e 27 to 615 32 to 620 exact AAA   589/620
(95 %)
0 diff
(100 %id)
TI_57163608   .e 27 to 608 30 to 611 exact AAA   582/611
(95 %)
0 diff
(100 %id)
TI_59392400   .e 27 to 608 88 to 669 exact AAA   582/582
(100 %)
0 diff
(100 %id)
L05092   .e 27 to 608 1 to 582 exact     582/582
(100 %)
0 diff
(100 %id)
CR991744 T-Lymphocytes .e 27 to 608 1 to 582 exact AAA   582/582
(100 %)
0 diff
(100 %id)
CR988075 T-Lymphocytes .e 27 to 608 1 to 582 exact AAA   582/582
(100 %)
0 diff
(100 %id)
CR997246 T-Lymphocytes .e 27 to 615 1 to 589 exact AAA   589/589
(100 %)
0 diff
(100 %id)
CR975411 T-Lymphocytes .e 27 to 618 1 to 592 exact AAA   592/592
(100 %)
0 diff
(100 %id)
CR975651 T-Lymphocytes .e 27 to 608 1 to 582 exact     582/582
(100 %)
0 diff
(100 %id)
CR994853 T-Lymphocytes .e 27 to 616 1 to 590 exact AAA   590/590
(100 %)
0 diff
(100 %id)
TI_154103983   .e 27 to 608 674 to 93 exact AAA   582/900
(64 %)
0 diff
(100 %id)
BM909513 lymph, lymphoma, cell line .e 28 to 608 1 to 581 exact AAA   581/581
(100 %)
0 diff
(100 %id)
BQ064447 lymph, lymphoma, cell line .e 28 to 608 1 to 581 exact AAA   581/581
(100 %)
0 diff
(100 %id)
BQ421427 large cell carcinoma, lung .e 28 to 616 1 to 589 exact AAA   589/589
(100 %)
0 diff
(100 %id)
BU179335 epithelioid carcinoma, Pancreas .e 28 to 608 1 to 581 exact AAA   581/581
(100 %)
0 diff
(100 %id)
BQ653969 hepatocellular carcinoma, cell line, Liver .e 28 to 608 1 to 581 exact AAA   581/581
(100 %)
0 diff
(100 %id)
BU507625 leiomyosarcoma, uterus .e 28 to 608 1 to 581 exact AAA   581/581
(100 %)
0 diff
(100 %id)
AW161474 brain, frontal lobe .e 29 to 324 1 to 296   fully sequenced,   296/296
(100 %)
0 diff
(100 %id)
BI836053 pooled pancreas and spleen .e 29 to 608 1 to 580 exact AAA   580/580
(100 %)
0 diff
(100 %id)
BI856912 breast, mammary adenocarcinoma, cell line .e 29 to 608 8 to 587   AAA   580/587
(98 %)
6 diff
(99.0 %id)
BM564853 eye, retinoblastoma .e 29 to 608 1 to 580 exact AAA   580/580
(100 %)
0 diff
(100 %id)
BM549295 melanotic melanoma, skin .e 29 to 608 1 to 580 exact AAA   580/580
(100 %)
0 diff
(100 %id)
CA777086 Pancreas, Purified pancreatic islet .e 29 to 594 11 to 576 exact fully sequenced,   566/576
(98 %)
0 diff
(100 %id)
CF272316 Brain glioblastoma .e 29 to 608 1 to 580 exact AAA   580/580
(100 %)
0 diff
(100 %id)
BQ575876 Chondrosarcoma Grade II, Left Pelvis .e 29 to 608 598 to 19 exact AAA   580/589
(98 %)
0 diff
(100 %id)
BQ226981 melanotic melanoma, skin .e 30 to 610 1 to 581 exact     581/585
(99 %)
1 diff
(99.9 %id)
BU172768 melanotic melanoma, skin .e 30 to 608 1 to 579 exact AAA   579/579
(100 %)
0 diff
(100 %id)
BU521971 leiomyosarcoma, uterus .e 30 to 608 1 to 579 exact AAA   579/579
(100 %)
0 diff
(100 %id)
CR976526 T-Lymphocytes .e 30 to 608 1 to 579 exact AAA   579/579
(100 %)
0 diff
(100 %id)
CR998625 T-Lymphocytes .e 30 to 608 1 to 579 exact AAA   579/579
(100 %)
0 diff
(100 %id)
CR978014 T-Lymphocytes .e 30 to 615 1 to 586 exact AAA   586/586
(100 %)
0 diff
(100 %id)
X79234 placenta .e 30 to 618 1 to 589       589/591
(99 %)
11 diff
(98.2 %id)
BM908416 astrocytoma grade IV, cell line, brain .e 31 to 608 1 to 578   AAA   578/578
(100 %)
0 diff
(100 %id)
BU542831 carcinoma, cell line, Prostate .e 31 to 608 1 to 578   AAA   578/578
(100 %)
0 diff
(100 %id)
BM693699 eye, lens .e 31 to 324 1 to 294   fully sequenced,   294/294
(100 %)
0 diff
(100 %id)
BG398533 B-cells, primary B-cells from tonsils (cell line) .e 32 to 608 1 to 577   AAA   577/577
(100 %)
0 diff
(100 %id)
BG422228 Kidney, renal cell adenocarcinoma .e 32 to 608 1 to 577   AAA   577/577
(100 %)
0 diff
(100 %id)
BG575204 breast, mammary adenocarcinoma, cell line .e 32 to 616 1 to 585   AAA   585/585
(100 %)
0 diff
(100 %id)
BI858094 breast, mammary adenocarcinoma, cell line .e 32 to 608 1 to 577   AAA   577/577
(100 %)
0 diff
(100 %id)
BM051905 Burkitt lymphoma, lymph .e 32 to 608 1 to 577   AAA   577/577
(100 %)
0 diff
(100 %id)
CF130519 Chondrosarcoma Lung Metastasis cell lines, lung .e 32 to 616 1 to 585   AAA   585/585
(100 %)
0 diff
(100 %id)
CR986529 T-Lymphocytes .e 32 to 615 1 to 584   AAA   584/584
(100 %)
0 diff
(100 %id)
BI792328 Pancreas, Purified pancreatic islet .e 33 to 607 575 to 1       575/575
(100 %)
0 diff
(100 %id)
BM090991 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .e 33 to 608 576 to 1       576/576
(100 %)
0 diff
(100 %id)
BM313360 Pancreas, Purified pancreatic islet .e 33 to 616 584 to 1       584/584
(100 %)
0 diff
(100 %id)
CN269137 embryonic stem cells, DMSO-treated H9 cellline .e 33 to 608 1 to 576   AAA   576/576
(100 %)
0 diff
(100 %id)
CN269162 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 33 to 608 1 to 576   AAA   576/576
(100 %)
0 diff
(100 %id)
CN269248 embryonic stem cells, DMSO-treated H9 cellline .e 33 to 608 1 to 576   AAA   576/576
(100 %)
0 diff
(100 %id)
W00581 lung .e 33 to 324 1 to 290   fully sequenced,   290/290
(100 %)
0 diff
(100 %id)
BI831093 brain, medulla .e 33 to 608 1 to 576   AAA   576/576
(100 %)
0 diff
(100 %id)
BU149586 melanotic melanoma, cell line, skin .e 33 to 608 1 to 576   AAA   576/576
(100 %)
0 diff
(100 %id)
BQ680800 melanotic melanoma, cell line, skin .e 33 to 608 1 to 576   AAA   576/576
(100 %)
0 diff
(100 %id)
CR993375 T-Lymphocytes .e 33 to 608 1 to 576   AAA   576/576
(100 %)
0 diff
(100 %id)
CT001433 T-Lymphocytes .e 33 to 608 1 to 576   AAA   576/576
(100 %)
0 diff
(100 %id)
CR986239 T-Lymphocytes .e 33 to 611 1 to 579       579/580
(99 %)
1 diff
(99.9 %id)
CR994603 T-Lymphocytes .e 33 to 608 1 to 576   AAA   576/576
(100 %)
0 diff
(100 %id)
CT001339 T-Lymphocytes .e 33 to 608 1 to 576   AAA   576/576
(100 %)
0 diff
(100 %id)
CR993680 T-Lymphocytes .e 33 to 608 1 to 576   AAA   576/576
(100 %)
0 diff
(100 %id)
CR983202 T-Lymphocytes .e 33 to 615 1 to 583   AAA   583/583
(100 %)
0 diff
(100 %id)
AF432212   .e 34 to 612 1 to 579       579/579
(100 %)
0 diff
(100 %id)
BQ421679 large cell carcinoma, lung .e 34 to 608 1 to 575   AAA   575/575
(100 %)
0 diff
(100 %id)
BM699814 eye, lens .e 34 to 324 1 to 291   fully sequenced,   291/291
(100 %)
0 diff
(100 %id)
BG773739 choriocarcinoma, placenta .e 35 to 608 1 to 574   AAA   574/574
(100 %)
0 diff
(100 %id)
BG743949 blood, natural killer cells, cell line .e 35 to 534 1 to 500   fully sequenced, AAA   500/500
(100 %)
0 diff
(100 %id)
BM558648 amelanotic melanoma, cell line, skin .e 35 to 608 1 to 574   AAA   574/574
(100 %)
0 diff
(100 %id)
BQ049174 lymph, lymphoma, cell line .e 35 to 608 1 to 574   AAA   574/574
(100 %)
0 diff
(100 %id)
BM825344 Ascites, stomach .e 35 to 608 1 to 574   AAA   574/574
(100 %)
0 diff
(100 %id)
TI_149286971   .e 35 to 615 642 to 62   AAA   581/1092
(53 %)
0 diff
(100 %id)
TI_149293989   .e 35 to 616 674 to 93   AAA   582/942
(61 %)
0 diff
(100 %id)
TI_154023059   .e 35 to 608 660 to 87   AAA   574/684
(83 %)
0 diff
(100 %id)
TI_154030223   .e 35 to 608 656 to 83   AAA   574/982
(58 %)
0 diff
(100 %id)
TI_227715318   .e 35 to 608 676 to 103   AAA   574/962
(59 %)
0 diff
(100 %id)
BU682907 lung .e 35 to 616 600 to 19   AAA   582/591
(98 %)
0 diff
(100 %id)
BE886794 leiomyosarcoma, uterus .e 36 to 607 1 to 572       572/572
(100 %)
0 diff
(100 %id)
BF981007 duodenal adenocarcinoma, cell line, small intestine .e 36 to 608 1 to 573   AAA   573/573
(100 %)
0 diff
(100 %id)
BM809648 amelanotic melanoma, cell line, skin .e 36 to 608 1 to 573   AAA   573/573
(100 %)
0 diff
(100 %id)
BM458413 lymph, lymphoma, cell line .e 36 to 608 1 to 573   AAA   573/573
(100 %)
0 diff
(100 %id)
BM468287 leiomyosarcoma, uterus .e 36 to 608 1 to 573   AAA   573/573
(100 %)
0 diff
(100 %id)
BM472198 embryonal carcinoma, cell line, testis .e 36 to 608 1 to 573   AAA   573/573
(100 %)
0 diff
(100 %id)
BM479693 embryonal carcinoma, cell line, testis .e 36 to 608 1 to 573   AAA   573/573
(100 %)
0 diff
(100 %id)
BQ672843 epidermoid carcinoma, cell line, salivary gland .e 36 to 608 1 to 573   AAA   573/573
(100 %)
0 diff
(100 %id)
BQ642307 lymph, lymphoma, cell line .e 36 to 616 1 to 581   AAA   581/581
(100 %)
0 diff
(100 %id)
BU527520 epidermoid carcinoma, cell line, lung .e 36 to 608 1 to 573   AAA   573/573
(100 %)
0 diff
(100 %id)
BU845045 ovary, teratocarcinoma, cell line .e 36 to 608 1 to 573   AAA   573/573
(100 %)
0 diff
(100 %id)
BU955945 adenocarcinoma, cell line, breast .e 36 to 609 1 to 574       574/574
(100 %)
0 diff
(100 %id)
CR979004 T-Lymphocytes .e 36 to 609 1 to 574       574/574
(100 %)
0 diff
(100 %id)
CR996703 T-Lymphocytes .e 36 to 611 1 to 576       576/576
(100 %)
0 diff
(100 %id)
CA439291 lung, Metastatic Chondrosarcoma .e 36 to 608 591 to 19   AAA   573/573
(100 %)
0 diff
(100 %id)
AA130308 colon, tumor .e 37 to 444 1 to 410   fully sequenced,   410/410
(100 %)
3 diff
(99.3 %id)
BM904836 melanotic melanoma, skin .e 37 to 616 1 to 580   AAA   580/580
(100 %)
0 diff
(100 %id)
BU164614 large cell carcinoma, lung .e 37 to 616 1 to 580       580/584
(99 %)
1 diff
(99.9 %id)
TI_149273808   .e 37 to 618 75 to 656     Submitted on the opposite strand 582/965
(60 %)
25 diff
(97.5 %id)
BU857948 adenocarcinoma, cell line, breast .e 38 to 616 1 to 579   AAA   579/579
(100 %)
0 diff
(100 %id)
BU943995 adenocarcinoma, cell line, breast .e 38 to 608 1 to 571   AAA   571/571
(100 %)
0 diff
(100 %id)
BG574244 breast, mammary adenocarcinoma, cell line .e 39 to 608 1 to 570   AAA   570/570
(100 %)
0 diff
(100 %id)
BM048880 carcinoma, cell line, Prostate .e 39 to 608 1 to 570   AAA   570/570
(100 %)
0 diff
(100 %id)
BU789899 insulinoma, Pancreas .e 39 to 604 1 to 566   fully sequenced,   566/566
(100 %)
3 diff
(99.5 %id)
TI_149292977   .e 39 to 608 633 to 63   AAA   571/805
(70 %)
1 diff
(99.9 %id)
BU943470 carcinoma, cell line, Prostate .e 40 to 608 1 to 569   AAA   569/569
(100 %)
0 diff
(100 %id)
BM716200 eye, RPE and Choroid .e 40 to 618 1 to 579   fully sequenced, AAA   579/579
(100 %)
0 diff
(100 %id)
BM710254 eye, RPE and Choroid .e 40 to 456 1 to 417   fully sequenced,   417/417
(100 %)
0 diff
(100 %id)
AA132160   .e 41 to 375 1 to 339   fully sequenced,   339/339
(100 %)
3 diff
(99.2 %id)
AA143132   .e 42 to 438 1 to 398   fully sequenced,   398/398
(100 %)
2 diff
(99.5 %id)
BU948417 insulinoma, Pancreas .e 42 to 616 1 to 575   fully sequenced, AAA   575/575
(100 %)
4 diff
(99.4 %id)
TI_149309564   .e 45 to 608 647 to 84   AAA   564/930
(60 %)
0 diff
(100 %id)
CR625076 B cells (Ramos cell line) Cot 25-normalized .e 47 to 618 1 to 572       572/572
(100 %)
0 diff
(100 %id)
AA083774   .e 47 to 324 1 to 278   fully sequenced,   278/278
(100 %)
0 diff
(100 %id)
BG026305 Bone, osteosarcoma, cell line .e 48 to 615 1 to 568   AAA   568/568
(100 %)
0 diff
(100 %id)
CR989333 T-Lymphocytes .e 48 to 615 1 to 568   AAA   568/568
(100 %)
0 diff
(100 %id)
CR997602 T-Lymphocytes .e 48 to 615 1 to 568   AAA   568/568
(100 %)
0 diff
(100 %id)
CR993138 T-Lymphocytes .e 48 to 616 1 to 569   AAA   569/569
(100 %)
0 diff
(100 %id)
N68904 lung .e 263 to 611 350 to 2   fully sequenced,   349/350
(99 %)
0 diff
(100 %id)
AA083775   .e 263 to 608 346 to 1   fully sequenced,   346/346
(100 %)
0 diff
(100 %id)
AW161895 brain, frontal lobe .e 263 to 618 362 to 7   fully sequenced,   356/362
(98 %)
0 diff
(100 %id)
BG744629 blood, natural killer cells, cell line .e 263 to 565 305 to 1   fully sequenced,   305/305
(100 %)
0 diff
(100 %id)
BU948144 insulinoma, Pancreas .e 263 to 616 371 to 18   fully sequenced, AAA   354/354
(100 %)
0 diff
(100 %id)
CN478456 eye, lens .e 263 to 608 364 to 19   fully sequenced, AAA   346/346
(100 %)
0 diff
(100 %id)
BM670836 eye, lens .e 263 to 608 364 to 19   fully sequenced, AAA   346/346
(100 %)
0 diff
(100 %id)
N70594 lung .e 344 to 608 275 to 11   fully sequenced, AAA   265/265
(100 %)
0 diff
(100 %id)
AA132056   .e 345 to 608 283 to 20   fully sequenced, AAA   264/264
(100 %)
0 diff
(100 %id)
DB357637 whole embryo, mainly head .e 395 to 608 214 to 1   fully sequenced,   214/214
(100 %)
0 diff
(100 %id)
AA130309 colon, tumor .e 395 to 608 214 to 1   fully sequenced,   214/214
(100 %)
0 diff
(100 %id)
AA143072   .e 395 to 608 224 to 11   fully sequenced, AAA   214/214
(100 %)
0 diff
(100 %id)
BQ632103 Pancreas, Purified pancreatic islet .e 395 to 611 218 to 2   fully sequenced,   217/218
(99 %)
0 diff
(100 %id)
BU789627 insulinoma, Pancreas .e 395 to 607 213 to 1   fully sequenced,   213/213
(100 %)
0 diff
(100 %id)
CA776804 Pancreas, Purified pancreatic islet .e 395 to 609 215 to 1   fully sequenced,   215/215
(100 %)
0 diff
(100 %id)
BU732179 eye, RPE and Choroid .e 395 to 616 240 to 19   fully sequenced, AAA   222/222
(100 %)
0 diff
(100 %id)
BM664208 eye, RPE and Choroid .e 395 to 608 232 to 19   fully sequenced, AAA   214/214
(100 %)
0 diff
(100 %id)
BU600568 mixed (pool of 40 RNAs) .f 1 to 621 1 to 622 exact tiling clone, AAA   622/622
(100 %)
6 diff
(99.1 %id)
BU942075 mixed (pool of 40 RNAs) .f 1 to 623 1 to 624 R145A R146Q T147D G148R C149L ... tiling clone,   624/769
(81 %)
10 diff
(98.7 %id)
CD556222 embryonic trophoblasts, made from WA01 stemcells .f 16 to 335 22 to 340   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 319/1463
(21 %)
12 diff
(99.2 %id)
BQ277406 mixed (pool of 40 RNAs) .f 25 to 599 1 to 576 exact     576/580
(99 %)
6 diff
(99.0 %id)
BU935419 mixed (pool of 40 RNAs) .f 25 to 623 1 to 599 exact     599/603
(99 %)
4 diff
(99.4 %id)
BU953790 mixed (pool of 40 RNAs) .f 25 to 621 1 to 601 L174P P175S G176W K177Q AAA   601/601
(100 %)
12 diff
(98.1 %id)
CB956931 Pooled-Glandular .f 25 to 621 1 to 597 exact     597/598
(99 %)
4 diff
(99.4 %id)
CD520465 pooled .f 25 to 624 1 to 600 exact     600/736
(81 %)
4 diff
(99.5 %id)
CD522020 pooled .f 25 to 635 1 to 611 exact     611/837
(72 %)
10 diff
(98.9 %id)
BF695471 brain, primitive neuroectoderm .f 26 to 623 1 to 596 F165V Q166P Q167A K168E Y169V ...     596/850
(70 %)
6 diff
(99.3 %id)
BG503674 embryonal carcinoma, testis .f 26 to 619 1 to 595 exact     595/625
(95 %)
7 diff
(98.9 %id)
BQ435654 testis .f 26 to 624 1 to 600 exact     600/600
(100 %)
5 diff
(99.2 %id)
BF674196 Prostate .f 27 to 608 1 to 575 F106L I108S Q109R E110N H111T ...     575/832
(69 %)
16 diff
(98.1 %id)
BF699868 brain, primitive neuroectoderm .f 27 to 622 1 to 595 E27R S28V G29E D30T R31D ...     595/637
(93 %)
7 diff
(99.0 %id)
BG531841 embryonal carcinoma, testis .f 27 to 621 1 to 597 exact     597/835
(71 %)
10 diff
(98.9 %id)
BG615088 embryonal carcinoma, testis .f 27 to 630 1 to 603 F104L G105V F106W G107D I108P ...     603/871
(69 %)
9 diff
(99.0 %id)
CD641091 pooled .f 27 to 620 1 to 591 exact AAA   591/591
(100 %)
8 diff
(98.7 %id)
BP225314   .f 28 to 609 1 to 582 exact     582/582
(100 %)
3 diff
(99.5 %id)
AV715577   .f 28 to 621 1 to 594 exact     594/698
(85 %)
3 diff
(99.6 %id)
CB985555 Pooled-Glandular .f 28 to 621 1 to 594 E83G K84E L86S V88G R89A ...     594/748
(79 %)
5 diff
(99.4 %id)
TI_44000609   .f 28 to 623 89 to 683 R17H G148A C149A I150L A152P ... AAA   595/861
(69 %)
10 diff
(98.9 %id)
TI_44000678   .f 28 to 623 94 to 687 R17H F104L G105V F106W G107D ...     594/775
(76 %)
14 diff
(98.2 %id)
BP283460 bone marrow .f 28 to 536 1 to 507       507/563
(90 %)
8 diff
(98.6 %id)
BM838666 lymph node, stomach .f 28 to 570 1 to 543       543/543
(100 %)
1 diff
(99.9 %id)
BM840619 lymph node, stomach .f 28 to 290 1 to 261       261/261
(100 %)
3 diff
(98.9 %id)
BP376512 uterus .f 28 to 610 1 to 583 exact     583/583
(100 %)
2 diff
(99.7 %id)
DA790185 brain .f 29 to 612 2 to 586 L42P T43H G44R Q45A T46D ... capped   585/585
(100 %)
1 diff
(99.9 %id)
DA958757 Spleen .f 29 to 574 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DB488119 hypothalamus .f 31 to 392 1 to 362       362/364
(99 %)
10 diff
(97.3 %id)
DB491495 hypothalamus .f 31 to 438 1 to 407       407/407
(100 %)
5 diff
(98.8 %id)
DB493972 hypothalamus .f 31 to 549 1 to 519       519/527
(98 %)
3 diff
(99.5 %id)
DB504595 hypothalamus .f 31 to 497 1 to 467       467/467
(100 %)
1 diff
(99.8 %id)
CN269203 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 32 to 584 1 to 553 exact     553/556
(99 %)
5 diff
(99.2 %id)
CN269215 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 32 to 631 1 to 600 exact tiling clone,   600/602
(99 %)
5 diff
(99.2 %id)
CV311463 head_neck .f 34 to 437 12 to 415       404/415
(97 %)
7 diff
(98.4 %id)
CN269200 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f 36 to 629 6 to 599 exact AAA   594/599
(99 %)
6 diff
(99.0 %id)
BM912002 amelanotic melanoma, cell line, skin .f 36 to 505 1 to 470       470/1405
(33 %)
8 diff
(99.5 %id)
BF975298 B-cells, primary B-cells from tonsils (cell line) .f 38 to 623 1 to 586 exact     586/607
(96 %)
3 diff
(99.6 %id)
BC018970 Primary B-Cells from Tonsils .f 39 to 621 1 to 583 exact available from MGC, AAA   583/583
(100 %)
0 diff
(100 %id)
BG032715 breast, mammary adenocarcinoma, cell line .f 39 to 595 1 to 557 exact AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 557/557
(100 %)
0 diff
(100 %id)
BM051548 Burkitt lymphoma, lymph .f 40 to 629 1 to 589 K87R V88C R89G E90S Y91M ... AAA   589/589
(100 %)
2 diff
(99.7 %id)
CN269163 embryonic stem cells, cell lines H1, H7, andH9 .f 41 to 536 13 to 508       496/508
(97 %)
0 diff
(100 %id)
BM461867 leiomyosarcoma, uterus .f 41 to 624 1 to 584 exact     584/587
(99 %)
1 diff
(99.9 %id)
AY871274   .f 42 to 601 1 to 560 T33A     560/560
(100 %)
1 diff
(99.9 %id)
BG475967 melanotic melanoma, skin .f 42 to 630 1 to 589 F104L F106L AAA   589/589
(100 %)
8 diff
(98.7 %id)
BG478138 melanotic melanoma, skin .f 42 to 631 1 to 590 exact     590/611
(96 %)
2 diff
(99.7 %id)
BM477627 leiomyosarcoma, uterus .f 42 to 621 1 to 580 exact     580/676
(85 %)
2 diff
(99.8 %id)
BQ328405 leiomios .f 43 to 229 1 to 187       187/187
(100 %)
0 diff
(100 %id)
BG286196 bladder, transitional cell papilloma, cell line .f 43 to 558 1 to 516       516/682
(75 %)
5 diff
(99.3 %id)
CR981379 T-Lymphocytes .f 43 to 608 1 to 566 exact     566/568
(99 %)
1 diff
(99.9 %id)
CR985426 T-Lymphocytes .f 43 to 631 1 to 589 exact     589/594
(99 %)
1 diff
(99.9 %id)
H57243 liver and spleen .f 44 to 308 13 to 280   fully sequenced,   268/280
(95 %)
3 diff
(99.0 %id)
BQ921437 leiomyosarcoma, uterus .f 44 to 621 1 to 578 exact AAA   578/578
(100 %)
0 diff
(100 %id)
W21379 lung .f 45 to 377 1 to 335   fully sequenced,   332/332
(100 %)
12 diff
(96.4 %id)
CB122703 Liver .f 45 to 592 1 to 548 exact     548/548
(100 %)
0 diff
(100 %id)
TI_1948083606   .f 45 to 337 133 to 425   fully sequenced,   293/320
(91 %)
0 diff
(100 %id)
TI_1948083766   .f 45 to 541 137 to 634       498/527
(94 %)
2 diff
(99.7 %id)
TI_1948083833   .f 45 to 576 139 to 670       532/1274
(41 %)
4 diff
(99.7 %id)
BI838131 pooled pancreas and spleen .f 47 to 528 1 to 483       483/485
(99 %)
2 diff
(99.6 %id)
BQ055276 lymph, lymphoma, cell line .f 47 to 631 1 to 585       585/612
(95 %)
5 diff
(99.2 %id)
BF726629 eye, lens .f 48 to 520 1 to 473       473/473
(100 %)
0 diff
(100 %id)
BG033694 breast, mammary adenocarcinoma, cell line .f 48 to 621 1 to 572   AAA   572/572
(100 %)
2 diff
(99.7 %id)
BG178965 adenocarcinoma, cell line, Prostate .f 48 to 606 1 to 558   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 558/558
(100 %)
1 diff
(99.9 %id)
BI862160 breast, mammary adenocarcinoma, cell line .f 48 to 631 1 to 585       585/601
(97 %)
4 diff
(99.4 %id)
BM562000 blood, natural killer cells, cell line .f 48 to 621 1 to 574   AAA   574/574
(100 %)
0 diff
(100 %id)
AA314102 colon .f 49 to 538 1 to 490       490/490
(100 %)
0 diff
(100 %id)
BF204185 muscle, rhabdomyosarcoma .f 49 to 622 1 to 574   AAA   574/574
(100 %)
10 diff
(98.3 %id)
BQ689130 ductal carcinoma, cell line, Pancreas .f 49 to 629 1 to 581   AAA   581/581
(100 %)
0 diff
(100 %id)
H44146 brain .f 50 to 381 1 to 337   fully sequenced,   337/337
(100 %)
3 diff
(99.2 %id)
BQ716954 sympathetic trunk .f 50 to 621 1 to 572       572/573
(99 %)
1 diff
(99.9 %id)
H57167 liver and spleen .f 276 to 549 299 to 26   fully sequenced,   274/299
(91 %)
4 diff
(98.7 %id)
TI_1948083607   .f 276 to 578 432 to 130   fully sequenced,   303/432
(70 %)
0 diff
(100 %id)
N93027 lung .f 347 to 624 279 to 1   fully sequenced,   279/279
(100 %)
2 diff
(99.3 %id)
H44067 brain .f 351 to 572 224 to 3   fully sequenced,   222/224
(99 %)
1 diff
(99.6 %id)
DA101305 cerebellum .g 1 to 567 2 to 568 exact tiling clone, capped   567/567
(100 %)
1 diff
(99.9 %id)
BI115140 muscle, rhabdomyosarcoma .g 16 to 728 1 to 720 exact     720/744
(96 %)
22 diff
(97.1 %id)
BP423649 small intestine .g 224 to 788 1 to 564   tiling clone, Submitted on the opposite strand 564/564
(100 %)
1 diff
(99.9 %id)
DB240193 trachea .h 1 to 577 2 to 578   tiling clone, capped   577/577
(100 %)
1 diff
(99.9 %id)
BM547102 brain, hippocampus .h 31 to 901 20 to 891   tiling clone,   872/1089
(80 %)
18 diff
(98.4 %id)
BG032655 breast, mammary adenocarcinoma, cell line .h 500 to 1234 1 to 742       711/978
(72 %)
29 diff
(97.1 %id)
BG717039 testis .h 549 to 1374 1 to 818 F94L G95V F96W G97D I98P ... tiling clone, AAA   818/818
(100 %)
13 diff
(98.5 %id)
TI_154018824   .h 711 to 1378 802 to 135 R5C L11F A26T E30G E80G ...     668/802
(83 %)
25 diff
(96.9 %id)
CR626653 B cells (Ramos cell line) Cot 25-normalized .h 790 to 1378 1 to 589 exact tiling clone,   589/589
(100 %)
0 diff
(100 %id)
CR597577 Placenta Cot 25-normalized .h 794 to 1378 1 to 585 exact     585/585
(100 %)
0 diff
(100 %id)
BP248170 Kidney .i 1 to 581 1 to 581   tiling clone,   581/581
(100 %)
0 diff
(100 %id)
CN269209 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .i 238 to 994 1 to 757 exact tiling clone,   757/757
(100 %)
0 diff
(100 %id)
BE894781 melanotic melanoma, skin .i 242 to 1038 1 to 795 exact tiling clone,   795/1057
(75 %)
27 diff
(97.5 %id)
BX118515 germinal center B cell .i 674 to 1032 97 to 457       361/449
(80 %)
6 diff
(98.7 %id)
AA748897 germinal center B cell .i 909 to 1230 333 to 13   tiling clone, AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 321/321
(100 %)
3 diff
(99.1 %id)
AW297732   .i 985 to 1535 568 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 551/551
(100 %)
3 diff
(99.5 %id)
AI862742 lymph node, lymphoma, follicular mixed small and largecell .i 1038 to 1230 230 to 38   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 193/193
(100 %)
12 diff
(93.8 %id)
BG928353 cartilage .j 1 to 567 75 to 641 exact     567/583
(97 %)
10 diff
(98.3 %id)
CN269202 embryonic stem cells, cell lines H1, H7, andH9 .j 1 to 533 1 to 533 exact tiling clone,   533/533
(100 %)
1 diff
(99.9 %id)
BU789267 insulinoma, Pancreas .j 3 to 567 1 to 565 exact fully sequenced, AAA   565/565
(100 %)
5 diff
(99.2 %id)
TI_149304484   .j 4 to 567 657 to 94 exact AAA   564/951
(59 %)
5 diff
(99.5 %id)
TI_149309121   .j 4 to 567 656 to 93 exact AAA   564/947
(59 %)
5 diff
(99.5 %id)
TI_57179523   .j 5 to 518 33 to 545       513/546
(93 %)
7 diff
(98.8 %id)
TI_57190586   .j 7 to 567 87 to 648 C10L L11S N12Q I13H C14L ... AAA   562/562
(100 %)
1 diff
(99.9 %id)
TI_57228333   .j 7 to 567 56 to 614 E17R S18V G19E D20T R21D ... AAA   559/559
(100 %)
2 diff
(99.7 %id)
TI_149279636   .j 7 to 574 626 to 59 exact AAA   568/1192
(47 %)
4 diff
(99.7 %id)
BU071478 insulinoma, Pancreas .j 8 to 570 1 to 563 exact fully sequenced,   563/563
(100 %)
6 diff
(99.0 %id)
BU787862 insulinoma, Pancreas .j 8 to 545 1 to 538 exact fully sequenced,   538/538
(100 %)
5 diff
(99.1 %id)
TI_182940159   .j 10 to 567 652 to 95 exact AAA   558/1003
(55 %)
0 diff
(100 %id)
TI_154143279   .j 11 to 498 78 to 566   AAA   489/568
(86 %)
13 diff
(97.8 %id)
TI_154144518   .j 11 to 567 76 to 631 K134N A142G     556/589
(94 %)
6 diff
(99.0 %id)
TI_154144524   .j 11 to 575 77 to 640 R153P     563/592
(95 %)
11 diff
(98.2 %id)
EC526032 Prostate .j 12 to 111 1 to 100       100/100
(100 %)
0 diff
(100 %id)
BE293470 adenocarcinoma cell line, colon .j 12 to 495 504 to 21       484/504
(96 %)
0 diff
(100 %id)
BE293756 adenocarcinoma cell line, colon .j 12 to 495 504 to 21       484/504
(96 %)
0 diff
(100 %id)
BE305041 adenocarcinoma cell line, colon .j 12 to 563 1 to 552 exact     552/552
(100 %)
0 diff
(100 %id)
BE297241 muscle, rhabdomyosarcoma .j 12 to 569 1 to 558 exact     558/558
(100 %)
0 diff
(100 %id)
BE393110 endometrium, adenocarcinoma cell line, uterus .j 12 to 575 1 to 563 K167N     563/563
(100 %)
4 diff
(99.3 %id)
BE563169 adenocarcinoma, Pancreas .j 12 to 565 1 to 552 F94L G95V F96W G97D I98P ...     552/552
(100 %)
2 diff
(99.7 %id)
BE740833 adenocarcinoma cell line, ovary .j 12 to 566 1 to 555 exact     555/555
(100 %)
0 diff
(100 %id)
BE902256 choriocarcinoma, placenta .j 12 to 566 1 to 554 F96L I98S Q99R E100N H101T ...     554/554
(100 %)
1 diff
(99.9 %id)
BF128649 B-cells, primary B-cells from tonsils (cell line) .j 12 to 567 1 to 555 F49L G50A I51S R52G R53E ... AAA   555/555
(100 %)
3 diff
(99.5 %id)
BF791995 adrenal cortex carcinoma, cell line, adrenal gland .j 12 to 571 1 to 560 exact AAA   560/560
(100 %)
1 diff
(99.9 %id)
BG171167 hypernephroma, cell line, Kidney .j 12 to 567 1 to 554 F94L G95V F96W G97D I98P ... AAA   554/554
(100 %)
2 diff
(99.7 %id)
BG250323 adenocarcinoma, cell line, Liver .j 12 to 567 1 to 554 F94L G95V F96W G97D I98P ... AAA   554/554
(100 %)
2 diff
(99.7 %id)
TI_59391570   .j 12 to 567 132 to 687 exact tiling clone, AAA   556/556
(100 %)
2 diff
(99.7 %id)
TI_59393963   .j 12 to 575 120 to 683 exact AAA   564/591
(95 %)
7 diff
(98.9 %id)
CR986143 T-Lymphocytes .j 12 to 567 1 to 556 exact AAA   556/556
(100 %)
0 diff
(100 %id)
TI_149281210   .j 12 to 567 697 to 142 R5G F49C AAA   556/698
(79 %)
2 diff
(99.8 %id)
AA320078 adipose tissue, white .j 13 to 312 1 to 302       302/303
(99 %)
3 diff
(99.1 %id)
CN269211 embryonic stem cells, DMSO-treated H9 cellline .j 13 to 373 1 to 361       361/362
(99 %)
1 diff
(99.8 %id)
H66162 liver and spleen .j 13 to 301 1 to 294   fully sequenced,   294/294
(100 %)
0 diff
(100 %id)
AA188273   .j 13 to 544 1 to 539 Y120* fully sequenced,   539/539
(100 %)
17 diff
(96.9 %id)
BE249866 adenocarcinoma cell line, colon .j 13 to 567 1 to 555 exact AAA   555/555
(100 %)
0 diff
(100 %id)
BE278574 choriocarcinoma, placenta .j 13 to 567 1 to 555 Y44H AAA   555/555
(100 %)
1 diff
(99.9 %id)
BE272688 Kidney, renal cell adenocarcinoma .j 13 to 566 1 to 554 exact     554/554
(100 %)
0 diff
(100 %id)
BE261847 brain, neuroblastoma .j 13 to 570 1 to 559 L83F R84K N86K N87Q F88L ...     559/563
(99 %)
2 diff
(99.7 %id)
BE382320 brain, neuroblastoma .j 13 to 569 1 to 567 Y81L E82*     567/707
(80 %)
17 diff
(97.6 %id)
BE393369 endometrium, adenocarcinoma cell line, uterus .j 13 to 575 1 to 567 F94L G95V F96W G97D I98P ... AAA   567/567
(100 %)
13 diff
(97.8 %id)
BE875820 large cell carcinoma, undifferentiated, lung .j 13 to 563 1 to 551 exact     551/551
(100 %)
0 diff
(100 %id)
BE909069 epithelioid carcinoma, Pancreas .j 13 to 495 1 to 483       483/686
(70 %)
1 diff
(99.9 %id)
BE893937 melanotic melanoma, skin .j 13 to 577 1 to 564 R53*     564/860
(65 %)
8 diff
(99.1 %id)
BE794947 lung, small cell carcinoma .j 13 to 570 1 to 556 F94L G95V F96W G97D I98P ...     556/557
(99 %)
3 diff
(99.5 %id)
BE902420 choriocarcinoma, placenta .j 13 to 565 1 to 550 F94L G95V F96W G97D I98P ...     550/550
(100 %)
3 diff
(99.5 %id)
BF305849 muscle, rhabdomyosarcoma .j 13 to 568 1 to 559 exact AAA   559/559
(100 %)
4 diff
(99.3 %id)
BG287683 bladder, transitional cell papilloma, cell line .j 13 to 567 1 to 566 S129Q I130H A131C D132R K133T ... AAA   566/566
(100 %)
22 diff
(96.2 %id)
BI093761 cervix .j 13 to 554 1 to 542 exact     542/1029
(52 %)
8 diff
(99.3 %id)
BQ894561 lymph, lymphoma, cell line .j 13 to 567 1 to 555 exact AAA   555/555
(100 %)
0 diff
(100 %id)
BU538626 adenocarcinoma, cell line, breast .j 13 to 571 1 to 559 exact AAA   559/559
(100 %)
0 diff
(100 %id)
CB157966 Liver .j 13 to 393 1 to 381       381/381
(100 %)
0 diff
(100 %id)
BM789324 Ascites, stomach .j 13 to 535 1 to 523 exact     523/527
(99 %)
1 diff
(99.9 %id)
AW964529   .j 14 to 567 1 to 552 exact AAA   552/552
(100 %)
2 diff
(99.7 %id)
AA076308   .j 14 to 415 1 to 404   fully sequenced,   404/404
(100 %)
2 diff
(99.6 %id)
BE744193 adenocarcinoma cell line, ovary .j 14 to 565 1 to 552 exact     552/552
(100 %)
0 diff
(100 %id)
BE909641 epithelioid carcinoma, Pancreas .j 14 to 570 1 to 562 E100V H101T I102R D103S L104T ...     562/562
(100 %)
6 diff
(99.0 %id)
BM803214 duodenal adenocarcinoma, cell line, small intestine .j 14 to 567 1 to 554 exact AAA   554/554
(100 %)
0 diff
(100 %id)
AW583753 Islets of Langerhans, Pancreas .j 14 to 309 1 to 296       296/296
(100 %)
1 diff
(99.7 %id)
AW583804 Islets of Langerhans, Pancreas .j 14 to 366 1 to 353       353/353
(100 %)
0 diff
(100 %id)
AW406306 lymph .j 34 to 283 8 to 257   fully sequenced,   250/257
(97 %)
6 diff
(97.7 %id)
TI_154133456   .j 34 to 567 653 to 120   AAA   534/823
(64 %)
4 diff
(99.6 %id)
TI_154133505   .j 34 to 577 640 to 97       544/942
(57 %)
1 diff
(99.9 %id)
TI_154141959   .j 34 to 568 78 to 614       537/727
(73 %)
9 diff
(98.8 %id)
TI_154143288   .j 34 to 566 80 to 613       534/541
(98 %)
4 diff
(99.3 %id)
TI_154143889   .j 34 to 563 88 to 617       530/530
(100 %)
1 diff
(99.9 %id)
TI_154143905   .j 34 to 567 86 to 619       534/534
(100 %)
1 diff
(99.9 %id)
TI_154144070   .j 34 to 569 77 to 612       536/537
(99 %)
13 diff
(97.6 %id)
BM689968 eye, Retina Foveal and Macular .j 34 to 568 1 to 535   fully sequenced, AAA   535/535
(100 %)
5 diff
(99.1 %id)
TI_154142553   .j 35 to 572 91 to 628       538/762
(70 %)
9 diff
(98.9 %id)
TI_59393672   .j 55 to 542 59 to 546       488/488
(100 %)
0 diff
(100 %id)
TI_149278203   .j 58 to 575 651 to 134   AAA   518/622
(83 %)
18 diff
(97.2 %id)
TI_154144121   .j 69 to 568 82 to 581       500/504
(99 %)
1 diff
(99.9 %id)
EL948911 eyeball .j 81 to 574 1 to 496   AAA   496/496
(100 %)
10 diff
(98.0 %id)
CR601780 thymus .j 83 to 570 1 to 488       488/488
(100 %)
0 diff
(100 %id)
DB575838 hypothalamus .j 91 to 575 1 to 485     Submitted on the opposite strand 485/485
(100 %)
0 diff
(100 %id)
EL953207 eyeball .j 110 to 567 1 to 456   AAA   456/456
(100 %)
10 diff
(97.9 %id)
DB548535 hippocampus .j 123 to 575 1 to 453     Submitted on the opposite strand 453/453
(100 %)
0 diff
(100 %id)
DB565006 hypothalamus .j 127 to 575 1 to 449     Submitted on the opposite strand 449/449
(100 %)
0 diff
(100 %id)
DB546204 hippocampus .j 135 to 575 1 to 441     Submitted on the opposite strand 441/441
(100 %)
0 diff
(100 %id)
EL953277 eyeball .j 148 to 573 1 to 427   AAA   427/427
(100 %)
10 diff
(97.7 %id)
DB557578 hypothalamus .j 166 to 565 1 to 399     Submitted on the opposite strand 399/401
(99 %)
5 diff
(98.8 %id)
TI_154191184   .j 198 to 567 51 to 420   AAA   370/370
(100 %)
0 diff
(100 %id)
BE838602 prostate_normal .j 204 to 530 339 to 2       312/339
(92 %)
12 diff
(96.5 %id)
TI_154192408   .j 211 to 567 46 to 403   AAA   358/358
(100 %)
1 diff
(99.8 %id)
AA181194   .j 222 to 567 346 to 1   fully sequenced,   346/346
(100 %)
0 diff
(100 %id)
AW575971 lymph .j 222 to 567 363 to 18   fully sequenced, AAA   346/346
(100 %)
0 diff
(100 %id)
BU787587 insulinoma, Pancreas .j 222 to 567 365 to 20   fully sequenced, AAA   346/346
(100 %)
0 diff
(100 %id)
TI_154192556   .j 222 to 567 50 to 396   AAA   347/347
(100 %)
1 diff
(99.8 %id)
TI_154194778   .j 222 to 568 43 to 387       345/984
(35 %)
3 diff
(99.7 %id)
TI_151770605   .j 251 to 567 126 to 442   AAA   317/442
(71 %)
6 diff
(98.7 %id)
H66163 liver and spleen .j 271 to 566 305 to 6   fully sequenced,   300/305
(98 %)
4 diff
(98.7 %id)
BE838651 prostate_normal .j 273 to 567 1 to 306       303/306
(99 %)
28 diff
(90.9 %id)
AW001277 colon, colonic mucosa from 3 patients with Crohn'sdisease .j 305 to 520 216 to 1       216/216
(100 %)
15 diff
(93.1 %id)
AW804254 uterus .j 321 to 526 1 to 194       194/195
(99 %)
20 diff
(89.8 %id)
BU071263 insulinoma, Pancreas .j 354 to 567 230 to 17   fully sequenced, AAA   214/214
(100 %)
0 diff
(100 %id)
BU789007 insulinoma, Pancreas .j 354 to 567 231 to 18   fully sequenced, AAA   214/214
(100 %)
0 diff
(100 %id)
BU726643 eye, Retina Foveal and Macular .j 354 to 567 232 to 19   fully sequenced, AAA   214/214
(100 %)
0 diff
(100 %id)
AA773103 ovary .j 380 to 574 195 to 1       195/195
(100 %)
0 diff
(100 %id)
AA076379   .j 384 to 570 191 to 5   fully sequenced,   187/191
(97 %)
0 diff
(100 %id)
AA552151 colon .j 442 to 520 79 to 1       79/79
(100 %)
2 diff
(97.5 %id)
EC516767 Prostate .j 464 to 566 102 to 1       102/102
(100 %)
1 diff
(99.1 %id)
AA705764 heart .j 466 to 570 109 to 5       105/109
(96 %)
0 diff
(100 %id)
BG370372 normal head/neck tissue .j 471 to 570 101 to 2       100/123
(81 %)
1 diff
(99.2 %id)
GD155796   .j 474 to 567 1 to 94   AAA   94/94
(100 %)
4 diff
(95.8 %id)
GD158829   .j 474 to 566 1 to 93   AAA   93/93
(100 %)
1 diff
(99.0 %id)
GD158887   .j 474 to 567 1 to 94   AAA   94/94
(100 %)
1 diff
(99.0 %id)
GD136662   .j 481 to 570 9 to 98       90/108
(83 %)
3 diff
(97.3 %id)
GD153702   .j 499 to 567 1 to 69   AAA   69/69
(100 %)
2 diff
(97.2 %id)
EC445983 Prostate .j 506 to 570 1 to 62       62/62
(100 %)
6 diff
(90.4 %id)
CB409379 maxilla, pooled .k 1 to 487 1 to 487 exact tiling clone,   487/575
(84 %)
1 diff
(99.9 %id)
CN269142 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .l 1 to 693 3 to 695 exact tiling clone,   695/695
(100 %)
0 diff
(100 %id)
BM839979 myeloma .l 12 to 552 1 to 541 exact     541/541
(100 %)
0 diff
(100 %id)
BP354460   .l 12 to 588 1 to 578 exact     578/581
(99 %)
2 diff
(99.7 %id)
BP376229 uterus .l 12 to 576 1 to 566 exact     566/566
(100 %)
1 diff
(99.9 %id)
DA059984 cerebellum .l 13 to 543 2 to 532 exact capped   531/531
(100 %)
0 diff
(100 %id)
DA360940 subthalamic nucleus .l 13 to 502 2 to 491 exact capped   490/490
(100 %)
0 diff
(100 %id)
DA371023 thalamus .l 13 to 558 2 to 547 exact capped   546/546
(100 %)
0 diff
(100 %id)
DA878528 Prostate .l 13 to 581 2 to 571 V57C R58Q S59I F60L G61W ... capped   570/570
(100 %)
1 diff
(99.9 %id)
DA906614   .l 13 to 595 2 to 584 exact capped   583/583
(100 %)
0 diff
(100 %id)
DA946352 Spleen .l 13 to 566 2 to 556 R90P E91G Y92V E93* capped   555/555
(100 %)
1 diff
(99.9 %id)
DB017281 esophageal, tumor tissue .l 13 to 580 2 to 569 exact capped   568/568
(100 %)
0 diff
(100 %id)
DB269492 uterus .l 13 to 578 2 to 568 L43P T44H G45R Q46A T47D ... capped   567/567
(100 %)
3 diff
(99.5 %id)
DB269693 uterus .l 13 to 572 2 to 562 V57C R58Q S59I F60L G61W ... capped   561/561
(100 %)
2 diff
(99.7 %id)
DB454107 testis .l 15 to 491 1 to 477 exact     477/477
(100 %)
0 diff
(100 %id)
DB255812 uterus .l 15 to 573 2 to 560 K96E capped   559/559
(100 %)
2 diff
(99.7 %id)
BI836055 pooled pancreas and spleen .l 23 to 771 1 to 757       757/781
(96 %)
20 diff
(97.5 %id)
TI_57163610   .l 24 to 771 33 to 788       756/812
(93 %)
18 diff
(97.8 %id)
CN269148 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .l 25 to 471 9 to 455 E81K     447/455
(98 %)
1 diff
(99.8 %id)
BE884249 leiomyosarcoma, uterus .l 31 to 740 1 to 714       714/1066
(66 %)
21 diff
(98.1 %id)
BI767568 pooled lung and spleen .l 34 to 809 1 to 775   tiling clone,   775/775
(100 %)
5 diff
(99.4 %id)
BI912708 brain .l 34 to 913 1 to 884   tiling clone,   884/932
(94 %)
23 diff
(97.6 %id)
TI_57184303   .l 35 to 809 28 to 801       774/801
(96 %)
11 diff
(98.7 %id)
TI_57238375   .l 35 to 913 36 to 918       883/966
(91 %)
29 diff
(97.0 %id)
H69065 liver and spleen .l 819 to 1228 11 to 421   tiling clone,   411/421
(97 %)
5 diff
(98.9 %id)
TI_149313373   .l 839 to 1604 831 to 70       762/1081
(70 %)
12 diff
(98.9 %id)
BQ771891 Chondrosarcoma Grade II, Left Pelvis .l 946 to 1622 694 to 19   tiling clone, AAA   676/676
(100 %)
4 diff
(99.5 %id)
CF541386 lung .l 961 to 1604 646 to 3       644/646
(99 %)
2 diff
(99.7 %id)
AI819672 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .l 1159 to 1621 463 to 1       463/463
(100 %)
3 diff
(99.4 %id)
AI559216 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .l 1188 to 1615 428 to 1       428/428
(100 %)
1 diff
(99.8 %id)
AI961763 thymus, pooled .l 1190 to 1617 430 to 3   tiling clone,   428/430
(99 %)
1 diff
(99.8 %id)
H69066 liver and spleen .l 1240 to 1612 381 to 1       381/381
(100 %)
12 diff
(96.9 %id)
AA226392   .l 1286 to 1614 349 to 14   AAA   336/359
(93 %)
9 diff
(97.5 %id)
AW196616 adenocarcinoma, Pancreas .l 1304 to 1623 320 to 1   tiling clone,   320/320
(100 %)
0 diff
(100 %id)
DA931172 Spleen .m 1 to 723 2 to 724 exact tiling clone, capped   723/730
(99 %)
3 diff
(99.6 %id)
DA945414 Spleen .m 13 to 582 2 to 571 exact capped   570/570
(100 %)
0 diff
(100 %id)
BI911780 leukocyte .m 24 to 790 29 to 796 exact     768/796
(96 %)
3 diff
(99.7 %id)
TI_57233735   .m 24 to 790 29 to 796 exact     768/796
(96 %)
3 diff
(99.7 %id)
BQ706301 Spleen .m 35 to 911 1 to 887       887/935
(94 %)
21 diff
(97.8 %id)
CN269255 embryonic stem cells, DMSO-treated H9 cellline .m 45 to 755 9 to 719       711/719
(98 %)
6 diff
(99.2 %id)
CR982809 T-Lymphocytes .m 48 to 815 1 to 768       768/772
(99 %)
1 diff
(99.9 %id)
BU945354 mixed (pool of 40 RNAs) .m 106 to 932 1 to 831       831/831
(100 %)
24 diff
(97.2 %id)
BI836971 pooled pancreas and spleen .m 182 to 757 180 to 762       583/762
(76 %)
27 diff
(96.5 %id)
TI_57163997   .m 182 to 757 278 to 860       583/860
(67 %)
32 diff
(96.3 %id)
CV318120 placenta_normal .m 208 to 618 1 to 410       410/410
(100 %)
3 diff
(99.3 %id)
BX415724 thymus .m 235 to 1026 1 to 792   tiling clone,   792/792
(100 %)
5 diff
(99.4 %id)
BF770730 epid_tumor .m 241 to 631 30 to 424       395/424
(93 %)
12 diff
(97.2 %id)
BF770739 epid_tumor .m 250 to 472 1 to 223       223/223
(100 %)
2 diff
(99.2 %id)
CN269218 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .m 271 to 837 9 to 575       567/575
(98 %)
1 diff
(99.9 %id)
AW602403 breast .m 291 to 669 1 to 379       379/379
(100 %)
2 diff
(99.5 %id)
BF885516 testis_normal .m 387 to 892 513 to 9     Submitted on the opposite strand 505/517
(97 %)
0 diff
(100 %id)
BQ376539 testis_normal .m 387 to 839 23 to 472       450/472
(95 %)
6 diff
(98.8 %id)
BQ376538 testis_normal .m 398 to 833 1 to 434       434/434
(100 %)
5 diff
(98.9 %id)
FN090735 breast carcinoma .m 455 to 511 1 to 59       59/59
(100 %)
2 diff
(96.7 %id)
CN289481 embryonic stem cells, DMSO-treated H9 cellline .m 493 to 1292 1 to 801   tiling clone,   801/801
(100 %)
5 diff
(99.4 %id)
CA337140 posterior rhombomeres 5-8 (4 pooled) .m 891 to 1136 1 to 246   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 246/246
(100 %)
1 diff
(99.6 %id)
F34060 pectoral muscle (after mastectomy) .m 1129 to 1441 1 to 313   tiling clone,   313/313
(100 %)
9 diff
(97.2 %id)
DB332378 Spleen .m 1537 to 2046 510 to 1   tiling clone,   510/511
(99 %)
16 diff
(96.9 %id)
BX340900   .n 1 to 951 2 to 947 exact tiling clone,   947/951
(99 %)
10 diff
(99.0 %id)
CR597812 Placenta Cot 25-normalized .n 5 to 1978 1 to 1974 exact tiling clone,   1974/1974
(100 %)
0 diff
(100 %id)
AL554433 placenta, Placenta Cot 25-normalized .n 5 to 996 1 to 987 exact fully sequenced,   987/987
(100 %)
3 diff
(99.7 %id)
AL554381 placenta, Placenta Cot 25-normalized .n 966 to 1978 1013 to 1   fully sequenced,   1013/1013
(100 %)
34 diff
(96.7 %id)
AI831303 lymph node, lymphoma, follicular mixed small and largecell .n 1397 to 2015 618 to 1       618/618
(100 %)
2 diff
(99.7 %id)
BE675608 B-cell, chronic lymphotic leukemia .n 1397 to 2017 622 to 2       621/622
(99 %)
0 diff
(100 %id)
BX393104   .n 1434 to 1998 565 to 1       565/927
(60 %)
44 diff
(95.3 %id)
DB519546 testis .n 1559 to 2012 1 to 454     Submitted on the opposite strand 454/456
(99 %)
2 diff
(99.6 %id)
C15874   .n 1618 to 2021 1 to 401       401/401
(100 %)
5 diff
(98.8 %id)
AW439467 serous papillary carcinoma, high grade, 2pooled tumors, uterus .n 1714 to 2024 318 to 8   tiling clone,   311/318
(97 %)
0 diff
(100 %id)
DW408102 Liver .o 1 to 425 17 to 440 exact tiling clone,   424/443
(95 %)
11 diff
(97.6 %id)
DW409752 Liver .p 1 to 319 19 to 337 F50Y K85N K88Q     320/337
(94 %)
9 diff
(97.4 %id)
DA261652 caudate nucleus .p 1 to 577 2 to 578 exact tiling clone, capped   577/577
(100 %)
2 diff
(99.7 %id)
BF088458 head_neck .p 191 to 479 1 to 290       290/291
(99 %)
12 diff
(95.9 %id)
AI348652 carcinoid, lung .q 1 to 427 442 to 16 exact tiling clone, AAA   427/427
(100 %)
5 diff
(98.9 %id)
DA949516 Spleen .r-u 1 to 559 2 to 560   tiling clone, capped   559/559
(100 %)
0 diff
(100 %id)
CN314850 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .r-u 66 to 733 1 to 668       668/668
(100 %)
1 diff
(99.9 %id)
BE887569 leiomyosarcoma, uterus .r-u 238 to 965 1 to 730       730/1024
(71 %)
17 diff
(98.4 %id)
BF038018 adenocarcinoma, ovary .r-u 407 to 1100 1 to 693   AAA   693/918
(75 %)
11 diff
(98.9 %id)
BX390116 Neuroblastoma Cot 10-normalized .r-u 454 to 1281 1 to 827   tiling clone,   827/832
(99 %)
7 diff
(99.2 %id)
BX089840 lung .r-u 480 to 1231 1 to 753       753/753
(100 %)
1 diff
(99.9 %id)
BQ219504 epithelioid carcinoma, Pancreas .r-u 507 to 1328 1 to 829       829/873
(94 %)
16 diff
(98.2 %id)
FN107138 breast carcinoma .r-u 596 to 677 1 to 84       84/84
(100 %)
3 diff
(96.5 %id)
AV702072 adrenal gland .r-u 602 to 1214 1 to 614       614/614
(100 %)
5 diff
(99.2 %id)
AV702073 adrenal gland .r-u 602 to 1214 1 to 614       614/614
(100 %)
5 diff
(99.2 %id)
TI_149296386   .r-u 640 to 1502 909 to 62 exact AAA   848/923
(91 %)
46 diff
(95.1 %id)
BI856960 breast, mammary adenocarcinoma, cell line .r-u 645 to 1315 9 to 679       671/679
(98 %)
6 diff
(99.2 %id)
TI_57187746   .r-u 645 to 1315 63 to 733       671/679
(98 %)
6 diff
(99.2 %id)
TI_149296459   .r-u 687 to 1502 884 to 83 exact AAA   802/918
(87 %)
14 diff
(98.5 %id)
TI_154050134   .r-u 728 to 1502 857 to 92 exact AAA   766/956
(80 %)
11 diff
(98.9 %id)
TI_154109253   .r-u 732 to 1502 850 to 90 exact AAA   761/925
(82 %)
13 diff
(98.6 %id)
BU684404 lung, Primary Lung Cystic Fibrosis EpithelialCells .r-u 765 to 1502 752 to 19 exact AAA   734/736
(99 %)
4 diff
(99.5 %id)
TI_149290974   .r-u 799 to 1502 783 to 81 exact AAA   703/704
(99 %)
6 diff
(99.2 %id)
CA447753 Chondrosarcoma, Left Pelvis .r-u 833 to 1502 688 to 19 exact AAA   670/670
(100 %)
1 diff
(99.9 %id)
BM973735 lung .r-u 838 to 1502 683 to 19 exact AAA   665/665
(100 %)
2 diff
(99.7 %id)
CA413796 Chondrosarcoma Grade II, Left Pelvis .r-u 839 to 1502 682 to 19 exact AAA   664/664
(100 %)
2 diff
(99.7 %id)
AW451236   .r-u 922 to 1502 598 to 18 exact AAA   581/581
(100 %)
0 diff
(100 %id)
TI_154096519   .r-u 930 to 1502 652 to 79 W10C F41S C42V A43L T44H ... AAA   574/1283
(44 %)
30 diff
(97.7 %id)
DB333704 Spleen .r-u 934 to 1502 570 to 1 S13G     570/570
(100 %)
3 diff
(99.5 %id)
BQ010847 placenta .r-u 943 to 1502 577 to 18 exact AAA   560/560
(100 %)
4 diff
(99.3 %id)
AW170217 cervix .r-u 944 to 1502 559 to 1 exact     559/559
(100 %)
1 diff
(99.9 %id)
CB114101 Liver .r-u 977 to 1284 1 to 308   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 308/308
(100 %)
0 diff
(100 %id)
CA440082 lung, Metastatic Chondrosarcoma .r-u 1018 to 1504 504 to 17 exact tiling clone, AAA   488/488
(100 %)
2 diff
(99.6 %id)
BX381546 Placenta Cot 25-normalized .r-u 1054 to 1503 1 to 451 exact fully sequenced,   451/451
(100 %)
3 diff
(99.4 %id)
BX381545 Placenta Cot 25-normalized .r-u 1099 to 1470 372 to 1 exact fully sequenced,   372/372
(100 %)
0 diff
(100 %id)
AI423670 brain, glioblastoma (pooled) .r-u 1303 to 1394 92 to 1       92/92
(100 %)
0 diff
(100 %id)
AA902637 Kidney .r-u 1383 to 1503 121 to 1       121/121
(100 %)
0 diff
(100 %id)
FN059175 breast carcinoma .r-u 1392 to 1484 1 to 95       95/95
(100 %)
2 diff
(97.9 %id)
DA760877 tongue .s-u 1 to 783 2 to 790 exact tiling clone, capped   789/792
(99 %)
12 diff
(98.5 %id)
DB102373 thymus .t 1 to 557 2 to 555 exact tiling clone, capped   554/554
(100 %)
1 diff
(99.9 %id)
AL040065 testis .u 1 to 501 1 to 505   tiling clone,   505/505
(100 %)
4 diff
(99.3 %id)
DB058307 testis .u 26 to 556 2 to 533   tiling clone, capped   532/532
(100 %)
2 diff
(99.7 %id)
DA557753   .va 1 to 543 2 to 544 exact tiling clone, capped   543/543
(100 %)
1 diff
(99.9 %id)
102 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r-u, .s-u, .t, .u, .va Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI